Dermatology & Allergy · Full case

Urticaria & Angioedema

NICE CKS 2023BSACI 2022

6 weeksThreshold: acute (<6w) vs chronic (>6w) urticaria — changes investigation and management

4× doseUp to 4× standard non-sedating antihistamine is evidence-based for chronic spontaneous urticaria

ACE-IMost common drug cause of angioedema — bradykinin-mediated, NOT histamine; antihistamines do not reliably work

HAEHereditary angioedema: C1-EI deficiency; check C4 + C1q + C1-EI level/function; bradykinin-mediated

StridorLaryngeal angioedema: 999 + adrenaline IM immediately — can progress silently to fatal airway obstruction

NICE TA339Omalizumab (anti-IgE): licensed for chronic spontaneous urticaria refractory to antihistamines

70%Chronic urticaria with autoimmune/autoreactive mechanism — autoantibodies to IgE or FcεRI

<24hIndividual urticarial wheals: resolve within 24 hours. >24h + painful + bruising = urticarial vasculitis

📋 Clinical Stem — Chronic Itchy Hives with Lip Swelling

A 34-year-old nurse with 3 months of daily urticaria and intermittent angioedema currently on an ACE inhibitor

Ayesha Patel, a 34-year-old nurse, attends with a 3-month history of daily itchy wheals affecting her trunk, arms, and thighs, associated with intermittent lip and periorbital swelling. She has tried over-the-counter loratadine 10mg once daily with partial benefit. No consistent trigger has been identified. She has been progressively restricting her diet — cutting out dairy, wheat, nuts, and various additives — in an attempt to identify a food trigger, and has become anxious about eating in restaurants. She is on ramipril 5mg OD (started 8 months ago by cardiology for mild hypertension). She does not connect the ramipril to her symptoms. She is sleeping poorly due to the itch and is finding her nursing shifts difficult. Her quality of life is significantly impacted. No family history of similar symptoms. No known allergies.

This stem tests three critical clinical tasks: recognising ACE inhibitor angioedema (bradykinin-mediated; must stop immediately); distinguishing histamine-mediated from bradykinin-mediated angioedema; and correcting the patient's food allergy hypothesis with evidence-based explanation. The GP must stop the ramipril today — this is a same-consultation clinical obligation — while also optimising the antihistamine regimen for the concurrent chronic spontaneous urticaria.

Scenario A — Acute Urticaria Post-Penicillin 19-year-old, 4 days of widespread urticaria starting 2 days after amoxicillin course for tonsillitis. Drug-induced acute urticaria — stop amoxicillin, cetirizine 10mg BD for 5–7 days, no re-challenge, document penicillin allergy. Most acute drug-induced urticaria is IgE-mediated; formal allergy testing if penicillin is likely to be needed again.

Scenario B — Hereditary Angioedema (HAE) 28-year-old woman, recurrent episodes of non-itchy swelling of the face, hands, and abdomen since age 16, family history (mother had similar attacks). No urticaria. Bradykinin-mediated (not histamine). Antihistamines and adrenaline do not reliably work. Check C4 (screening), C1q, C1-EI level and function. Immunology referral urgently. Combined OCP absolute contraindication (oestrogen triggers HAE attacks).

Scenario C — Dermographic Urticaria (Factitious Urticaria) 25-year-old, itchy linear wheals appearing wherever skin is scratched or rubbed; no spontaneous lesions otherwise. Most common form of chronic inducible urticaria. Confirmed with dermographometer. Non-sedating antihistamine at up to 4× dose. Usually self-limiting over months-years. No dietary restriction needed.

Scenario D — Cold Urticaria 22-year-old, urticaria and severe generalised reaction when swimming in cold water or holding cold objects. Cold-triggered urticaria — risk of anaphylaxis on cold water immersion. Prescribe 2 × adrenaline auto-injectors (EpiPen). Avoid cold water immersion. Non-sedating antihistamine. Allergy clinic referral for cold stimulation testing.

Scenario E — Laryngeal Angioedema Emergency Patient attends with voice change, throat tightness, difficulty swallowing and stridor of 20-minute onset. History of ramipril use. Laryngeal angioedema — 999 + adrenaline IM 0.5mg (1:1000) immediately + lie flat + IV access + corticosteroids. Do not wait for investigations. This is a potentially fatal emergency. Document ACE-I as cause; stop permanently.

Key variables to adapt for Duration (acute vs chronic 6-week threshold), presence of angioedema (with or without urticaria), drug history (ACE inhibitors, NSAIDs, opioids, aspirin), family history (HAE), physical triggers (cold, pressure, exercise), autoimmune associations (thyroid disease, SLE), and response to antihistamines.

Steps:

Step 1

History Taking — Open Question First · Duration · Triggers · Drug History · Angioedema Screen · ICE

▲collapse

Urticaria history has three clinical priorities that must all be addressed: (1) Establish whether this is acute (<6 weeks) or chronic (>6 weeks) — this changes investigation and management completely. (2) Screen for angioedema, especially laryngeal — a missed progressive laryngeal angioedema is potentially fatal. (3) Take a complete drug history with specific focus on ACE inhibitors, NSAIDs, and opioids — ACE inhibitor angioedema is the most commonly missed drug cause and can develop at any time during therapy, not only at initiation.

🎓 Consultation opener — the most important question is in the drug history

"Before we go through everything in detail, I want to ask about your medications — I can see you're on ramipril. Have you noticed any connection between when you started that tablet and when the lip swelling began? ACE inhibitors — the type of blood pressure tablet ramipril is — are a recognised cause of angioedema and I want to explore that specifically."

ACE inhibitor angioedema can occur months to years after starting the drug — not just at initiation. Most patients and many clinicians do not make this connection. Asking about it specifically, early, is the most important diagnostic act in this consultation.

1A — Open question, then targeted history

Question to ask	Why it matters clinically	Changes what?
🟢 OPEN QUESTION"Can you describe what's been happening — what the skin looks and feels like, when it started, how long the individual patches last, and whether you've had any swelling anywhere?"	The spontaneous narrative reveals the urticaria pattern, the duration, and any angioedema features without clinical prompting. A patient who says "itchy red raised patches that come and go within a few hours, and sometimes my lips swell up" has provided the diagnostic triad of urticaria (wheals, pruritus, transience) plus angioedema. The phrase "come and go within hours" — spontaneously offered — is the most specific feature distinguishing urticaria from fixed rashes.In SCA: a candidate who starts with "is it itchy?" has led the key diagnostic question. The open narrative allows the patient to use their own language for the severity and impact — which is also the most authentic ICE data you will collect.	Urticaria pattern confirmed; angioedema present?Duration: acute vs chronic
Duration of symptoms and classification"How long have you had these symptoms in total? And how long does each individual patch or swelling last — hours, or more than a day?"	The 6-week threshold separates acute from chronic urticaria and determines the investigation pathway. Acute urticaria (<6 weeks): often viral, drug-induced, or idiopathic; investigations rarely change management; antihistamine + avoid precipitant. Chronic urticaria (≥6 weeks): investigations warranted (FBC, TFTs, autoimmune screen); often chronic spontaneous urticaria (CSU) with autoimmune mechanism. The duration of individual wheals is equally important: <24 hours = urticaria; >24 hours + painful + resolves with bruising = urticarial vasculitis (requires biopsy, not just antihistamine).Urticarial vasculitis is an important misdiagnosis to avoid — it is an immune complex-mediated vasculitis associated with SLE, hepatitis B/C, and malignancy. Treating it as standard urticaria with antihistamines misses a potentially serious underlying diagnosis.	Acute vs chronic vs urticarial vasculitisChronic: investigations warrantedUrticarial vasculitis: biopsy + rheumatology
Angioedema — location, severity, and airway screen"You mentioned lip swelling — has the swelling ever affected your tongue, your throat, or made it difficult to breathe or swallow? Any voice change or noisy breathing?"	This question determines whether this is a routine chronic urticaria consultation or a potential airway emergency. Angioedema involving the tongue, pharynx, or larynx can progress silently before stridor develops. A patient who reports previous episodes of throat tightness, voice change, or difficulty swallowing is at risk of laryngeal angioedema. These patients require an adrenaline auto-injector prescribed today. Any current throat, tongue, or laryngeal symptoms = 999 immediately.Laryngeal angioedema can develop from apparent lip-only angioedema within minutes. The history of previous episodes involving the throat is the key risk stratification question. Prescribing two adrenaline auto-injectors (EpiPen 300mcg) for any patient with a history of facial/throat angioedema is standard practice.	Throat/tongue/laryngeal symptoms: 999 nowHistory of throat involvement: prescribe 2× EpiPen
ACE inhibitor and complete drug history"Can I ask specifically about your blood pressure tablets — ramipril or any similar medication? And any other medications including over-the-counter NSAIDs (ibuprofen, aspirin), codeine, or new vitamins?"	ACE inhibitor-induced angioedema is the most commonly missed drug cause. ACE inhibitors cause bradykinin accumulation (by inhibiting ACE, which normally breaks down bradykinin) — bradykinin-mediated angioedema is NOT histamine-mediated and does NOT respond reliably to antihistamines or adrenaline. Key features: predominantly facial/oropharyngeal angioedema; no urticaria or itch; can occur months or years after starting the drug; cumulative lifetime risk ~0.5% for ACE inhibitors. NSAIDs and aspirin can aggravate pre-existing urticaria (COX-1 inhibition shifting arachidonic acid towards leukotriene synthesis). Opioids cause direct mast cell degranulation (non-IgE mechanism).10–15% of patients switched from ACE inhibitor to ARB (angiotensin receptor blocker) also develop angioedema — the risk is lower but not negligible. Ramipril should be stopped permanently; candesartan or losartan are alternatives with lower cross-reactivity risk.	ACE-I identified: stop today; switch to CCB or ARB with cautionACE-I angioedema (bradykinin) vs allergic (histamine)
Trigger identification — systematic screen"Have you noticed anything that consistently triggers the hives or swelling? Exercise, heat, cold, pressure, stress, alcohol, specific foods, periods of the menstrual cycle?"	Physical urticaria (chronic inducible urticaria) is triggered by specific physical stimuli and accounts for a significant minority of chronic urticaria cases. Cold urticaria carries a risk of anaphylaxis on cold water immersion — these patients need EpiPens. Pressure urticaria (delayed pressure urticaria) takes 4–6 hours to develop after pressure — patients may not connect it to, for example, wearing tight clothing. Exercise-induced urticaria/anaphylaxis: wheat-dependent exercise-induced anaphylaxis is a specific form requiring exercise restriction after wheat ingestion. Stress aggravates all forms of urticaria by lowering the mast cell degranulation threshold.Most chronic spontaneous urticaria (CSU) has no identifiable trigger — 70% is autoreactive (autoantibodies to IgE or its receptor). Extensive dietary restriction seeking a food trigger is almost never productive in CSU and should be discouraged.	Chronic inducible vs chronic spontaneous urticariaCold urticaria: EpiPen; avoid cold immersion
Food allergy hypothesis — gently challenge"You mentioned avoiding various foods. Have you actually noticed that eating specific foods reliably triggers an episode within 1–2 hours? Or is the connection more uncertain?"	Food allergy as a cause of chronic urticaria is rare and overdiagnosed. True food-triggered urticaria occurs within 1–2 hours of ingestion and is reproducible. In chronic spontaneous urticaria, dietary restriction rarely identifies a trigger and progressive restriction creates nutritional risk, social isolation, anxiety, and eating disorder behaviour. The EAACI guideline advises against elimination diets in CSU without specific IgE-confirmed allergy. Confirming that no reliable food-symptom connection exists is both clinically important and therapeutically reassuring for Ayesha.Pseudoallergens (artificial colourings, preservatives, salicylates) can aggravate existing CSU in a minority of patients — but this is distinct from IgE-mediated food allergy and does not require food avoidance, only reduction of high-pseudoallergen foods if clearly symptomatic.	Diet restriction: reassure and advise to stopSpecific IgE testing only if reproducible food-symptom link
Family history — HAE screen"Has anyone in your family had recurrent unexplained swelling — particularly of the face, hands, abdomen, or throat — that is not itchy and doesn't come with hives?"	Hereditary angioedema (HAE) presents as recurrent episodes of non-itchy angioedema WITHOUT urticaria — this is the key distinguishing feature. HAE is autosomal dominant — C1-esterase inhibitor deficiency or dysfunction (Type 1: low level; Type 2: low function; Type 3: oestrogen-sensitive). Family history is positive in 75% of cases; de novo mutations account for 25%. The swelling of HAE is bradykinin-mediated, not histamine-mediated — antihistamines and adrenaline do NOT reliably work. Combined OCP is absolutely contraindicated in HAE (oestrogen triggers attacks).HAE abdominal attacks mimic surgical abdomen — patients may undergo unnecessary laparotomies before the diagnosis is made. Any patient with recurrent unexplained abdominal pain + peripheral oedema should have HAE excluded with C4 (screening test — reliably low during attacks and often between attacks).	HAE vs acquired angioedema vs histaminergicScreen with C4, C1q, C1-EI level/functionImmunology referral if HAE suspected
Autoimmune and thyroid history"Do you have any autoimmune conditions — thyroid disease, coeliac, lupus, or inflammatory bowel disease? Have you had any joint pains, skin rashes, or unexplained fatigue?"	Chronic spontaneous urticaria has a strong autoimmune association — 70% have autoreactive mechanisms (IgG autoantibodies against IgE or the high-affinity IgE receptor FcεRI). Associated autoimmune conditions include autoimmune thyroid disease (Hashimoto's, Graves'), SLE, and coeliac disease. TFTs and thyroid autoantibodies are part of the standard chronic urticaria screen. Treating underlying autoimmune thyroid disease does not reliably resolve CSU, but documenting the association is important for monitoring.Urticarial vasculitis (a separate condition from CSU) is associated with SLE — hypocomplementaemia (low C3, C4) in a patient with urticaria-like lesions lasting >24h should trigger SLE screen and rheumatology referral.	TFTs + thyroid autoantibodies in chronic urticaria screenUrticarial vasculitis: ANA, dsDNA, complement
Quality of life — UAS7 and sleep"How much is this affecting your day-to-day life — your sleep, your work, your enjoyment of activities? On a scale where 0 is fine and 10 is the worst imaginable, where are you?"	The Urticaria Activity Score (UAS7) is the validated disease activity tool for CSU: it scores the number of wheals and itch severity over 7 days (0–42). UAS7 is used to determine referral thresholds and monitor treatment response. More practically, the impact of chronic urticaria on sleep, work performance, and psychological wellbeing is significant — sleep deprivation from nocturnal pruritus reduces immune function, increases stress-related urticaria flares, and causes depression. Quantifying this impact is essential for selecting treatment urgency.Sedating antihistamines (chlorphenamine, hydroxyzine) should NOT be first-line in urticaria — they are less effective, cause impairment (important for a nurse), and have a short duration of action. They can be used short-term for nocturnal itch while non-sedating antihistamines are titrated up.	High UAS7 → up-dose antihistamine to 4× standardUAS7 ≥28 despite treatment: specialist/omalizumab
Previous treatments and response"What medications have you tried for this — prescribed or over-the-counter? How much relief did they give? Did you try increasing the dose of the antihistamine?"	Many patients with CSU use standard doses of antihistamines (cetirizine 10mg once daily) without knowing that up to 4× the standard dose is evidence-based and recommended by BSACI and EAACI guidelines for CSU. A patient who says "the loratadine helps a bit but not enough" may simply be undertreated — dose escalation before changing drug class or adding agents is the appropriate step. Previous sedating antihistamine use in a healthcare worker is a specific occupational safety concern that should be identified and addressed.	Antihistamine under-dosed: up to 4× standard (BSACI/EAACI)Partial response ≠ wrong drug; may be under-dose

1B — Red flags: must not miss · must ask · must act

🚨

Red Flags — act before continuing history

Red flag	Why dangerous	Action
Throat tightness, voice change, stridor, difficulty breathing or swallowing — any current symptoms	Laryngeal angioedema can progress silently from lip/tongue swelling to fatal airway obstruction within minutes. Stridor indicates the airway is already critically compromised. Adrenaline must be given immediately. Even if the patient appears stable, any current laryngeal symptoms = 999 + adrenaline IM without delay.	999 + adrenaline IM 0.5mg (1:1000) immediately
Rapidly progressive angioedema — lips, tongue, or facial swelling enlarging during the consultation	Progressive angioedema, even without stridor, represents an advancing airway threat. Adrenaline and emergency services must be called before the airway is compromised — not after stridor develops. By the time stridor appears, the airway has already narrowed by >75%.	999 + adrenaline IM; do not wait for stridor
Urticarial lesions lasting >24 hours, painful or burning rather than itchy, resolving with ecchymosis (bruising)	Urticarial vasculitis — an immune complex-mediated vasculitis that mimics urticaria but has entirely different pathology and management. Associated with SLE, hepatitis B/C, and haematological malignancy. Requires biopsy for diagnosis. Antihistamines do not treat it. Hypocomplementaemia (low C3, C4) is present in severe cases.	Biopsy + complement screen + ANA/dsDNA + rheumatology referral
Recurrent angioedema WITHOUT urticaria and WITHOUT itch — especially facial, hands, abdomen, family history	Hereditary angioedema (HAE) or ACE inhibitor angioedema — both bradykinin-mediated. HAE: antihistamines and adrenaline do NOT reliably work; specific treatments needed (C1-EI concentrate, icatibant). Abdominal HAE attacks mimic surgical abdomen and have led to unnecessary laparotomies. Diagnosis and emergency treatment plan before the next attack is essential.	Urgent immunology referral; C4, C1q, C1-EI level/function; icatibant prescription
Urticaria in the context of haemodynamic compromise — hypotension, tachycardia, dizziness, collapse	Anaphylaxis — urticaria is the most common skin manifestation of anaphylaxis (present in ~90% of cases). If urticaria is accompanied by cardiovascular or respiratory compromise, this is anaphylaxis, not simple urticaria. Immediate adrenaline IM + 999 + lie flat + IV access.	999 + adrenaline IM + lie flat

🛡️

Safeguarding Considerations

🚗 Occupational Safety — Driving and Antihistamines

Sedating antihistamines (chlorphenamine, hydroxyzine) impair driving and operating machinery — critical safety issue for a nurse or any professional requiring full alertness
Non-sedating antihistamines (cetirizine, loratadine, fexofenadine) are appropriate for healthcare workers; document the choice and the reason in notes
DVLA: first-generation antihistamines and driving — advise patients explicitly; document the conversation

💊 EpiPen Prescribing and Self-Injection Training

Every patient with a history of throat/tongue/laryngeal angioedema should be prescribed two adrenaline auto-injectors (EpiPen 300mcg or Emerade 300mcg) and trained in self-injection
Prescribe two because one may fail or the second dose may be needed while waiting for the ambulance
Training documentation: confirm patient understands when to use it (symptoms involving throat, breathing difficulty, collapse), how to use it, and that 999 must still be called even after using EpiPen

🤰 Contraception in Angioedema

Combined OCP: absolute contraindication in HAE — oestrogen triggers bradykinin-mediated attacks by increasing kinin production. Must be stopped immediately if HAE is diagnosed or suspected
Oestrogen-containing contraception in urticaria (without HAE): generally safe; some women report cyclical premenstrual flares of CSU which can worsen on the pill or improve depending on the individual
Progestogen-only options are safe in HAE — POP, implant, Mirena IUS are all appropriate alternatives

🍽️ Nutritional Risk from Dietary Restriction

Patients pursuing extensive dietary elimination to identify urticaria triggers are at risk of nutritional deficiency (calcium if dairy-free, fibre and B vitamins if wheat-free), disordered eating behaviours, and social isolation
Reassurance that food allergy is rarely the cause of chronic spontaneous urticaria — and that diet restriction is unlikely to help — is a clinical obligation
Dietitian referral if significant nutritional compromise from restriction. ARFID-like pattern emerging: CAMHS or eating disorder team involvement

If safeguarding concerns: Laryngeal angioedema: confirm EpiPen prescription and training documented. Sedating antihistamine in a nurse: switch to non-sedating immediately; document. Dietary restriction: reassure and support stopping restriction unless specific IgE-confirmed allergy. HAE: stop combined OCP immediately; provide emergency treatment plan.

1C — PMH · Drug history · Social history

🧬 PMH / Family history — changes management

Factor	Why it matters	Management impact
Autoimmune thyroid disease (Hashimoto's/Graves')	Associated with CSU in ~30% — autoimmune mechanism. Thyroid peroxidase (TPO) antibodies elevated in 25% of CSU without overt thyroid dysfunction	TFTs + TPO antibodies in chronic urticaria screen. Treating hypothyroidism, if present, may modestly reduce CSU activity in some patients.
Systemic lupus erythematosus (SLE)	Urticarial vasculitis is a known SLE manifestation — lesions >24h, painful, hypocomplementaemia. Standard urticaria treatment inadequate; immunosuppression required	ANA, dsDNA, C3, C4 in screen. Rheumatology referral if urticarial vasculitis suspected. Low C4 in urticaria + arthralgia + photosensitivity = urgent SLE workup.
Hereditary angioedema (HAE) — family history	Autosomal dominant; 75% have positive family history; 25% de novo mutations. Non-itchy angioedema without urticaria. C1-EI deficiency/dysfunction. Bradykinin-mediated.	Urgent immunology referral. Check C4 (most sensitive screen — low between attacks). C1q low in acquired angioedema but normal in HAE. Treatment: C1-EI concentrate or icatibant for attacks. Lanadelumab for prophylaxis.
Atopic history (asthma, eczema, hay fever)	Atopy predisposes to IgE-mediated allergic reactions but does NOT make chronic spontaneous urticaria more likely — CSU is usually NOT IgE-mediated. Atopic history can lead to unnecessary specific IgE testing panels	Do not request extensive specific IgE testing based on atopy alone. Only test if there is a specific, reproducible allergen-symptom link. Allergen panel testing without a specific hypothesis is unhelpful and expensive.
Previous anaphylaxis	Prior anaphylaxis with urticaria is the strongest predictor of future anaphylaxis. Risk of recurrence is high if re-exposure to same trigger. BSACI: all previous anaphylaxis patients should have allergy specialist follow-up and carry two EpiPens	Two EpiPen prescriptions. Allergy clinic referral. BSACI anaphylaxis action plan issued. Trigger avoidance education. Medical alert bracelet.

💊 Drug history — the most important diagnostic element

Drug / factor	Why it matters	Action
ACE inhibitors (ramipril, lisinopril, enalapril, perindopril)	Cause bradykinin-mediated angioedema — NOT histamine. Can occur at any time during therapy. Predominantly facial/oropharyngeal. Not itchy. Antihistamines do not reliably work. Lifetime risk ~0.5% of ACE-I users	Stop ACE inhibitor permanently today. Do not wait — this is a same-consultation decision. Switch to calcium channel blocker (amlodipine 5mg OD) first choice for BP. If must use RAAS agent: candesartan or losartan (ARB) — 10–15% cross-reactivity risk; counsel and monitor carefully. Document ACE-I as cause in allergy section.
NSAIDs and aspirin (COX-1 inhibitors)	Aggravate pre-existing urticaria in ~30% of CSU patients via leukotriene pathway (not IgE). Also can trigger acute urticaria independently. Not a true allergy — NSAID-exacerbated chronic urticaria (NECU)	If clear NSAID exacerbation: avoid NSAIDs and aspirin. Paracetamol as alternative — does not affect urticaria via this mechanism. If aspirin needed for CVD: very low dose (75mg) has much lower risk than full analgesic doses. Document in notes.
Opioids (codeine, morphine, tramadol)	Direct mast cell degranulation (non-IgE mechanism) — causes urticaria and flushing. Common cause of drug-induced urticaria in hospital setting. Not a true allergy — a pharmacological effect	Avoid opioids where possible in urticaria-prone patients. If opioid required: fentanyl and buprenorphine have lower mast cell degranulation properties. Antihistamine pre-medication can reduce reactions.
Combined oral contraceptive pill	Oestrogen-containing OCP is absolutely contraindicated in HAE (triggers attacks). In CSU without HAE: may cause cyclical flares or improvements — individual variation; not a contraindication but worth noting if cyclical pattern	HAE suspected: stop COC immediately; switch to POP, implant, or IUS. CSU only: if cyclical premenstrual flare pattern, review OCP timing in relation to symptom diary.
Food supplements (high-dose Vitamin C, herbal remedies)	Some herbal preparations (echninacea, bee products, royal jelly) can cause urticaria through IgE or direct mast cell effects. High doses of NAC or Vitamin B supplements can occasionally trigger reactions	Complete supplement history. If supplement coincides with urticaria onset: trial withdrawal for 4 weeks to assess response. No need for formal allergy testing for supplements without a specific temporal link.

1D — ICE: Ideas · Concerns · Expectations

Ayesha's explanatory model — that her urticaria is caused by a food allergy — is driving increasingly restrictive dietary behaviour that is not clinically indicated, is causing nutritional and social harm, and is preventing her from focusing on the actual causes (ramipril and likely CSU). The ICE conversation must gently but clearly challenge this model with evidence, without being dismissive. Her concern is not unreasonable — patients with chronic urticaria frequently do have food allergy blamed and investigated by multiple clinicians. What she needs is an authoritative, compassionate explanation of why chronic spontaneous urticaria is rarely food-driven, combined with the revelation about ramipril.

💭 Ideas

"You mentioned you have been restricting your diet — what is your theory about what might be causing the symptoms? Have you identified anything specific, or is it more of a suspicion that something you are eating is responsible?"

Identifying the food allergy hypothesis explicitly allows you to address it directly. If the patient says "I think it might be dairy" — you can explain why chronic urticaria lasting 3 months is very unlikely to be purely food-driven and why the drug history is more relevant. This is more therapeutically powerful than simply advising "stop the ramipril" without addressing the model she has built.

😟 Concerns

"What is worrying you most about the symptoms — the discomfort and sleep disruption, the swelling episodes, or is there something more frightening that you have been thinking about?"

Nurses often have specific fears based on clinical experience — she may be concerned about angioedema progressing to anaphylaxis or about an underlying cancer (urticaria can rarely be paraneoplastic). Naming the possibility that she might be afraid of something more serious allows her to disclose this fear and allows you to address it directly.

🎯 Expectations

"What were you hoping we would do today — allergy testing, a referral, different medication, or something else?"

A nurse patient may arrive with a very specific expectation (allergy testing panel, referral to allergy clinic). Meeting this expectation or explaining why the approach is different (drug history first, antihistamine optimisation, then referral only if needed) requires knowing what the expectation is first. Doing the investigation she expects when it is not indicated is not better medicine because she is a nurse.

1E — Psychosocial context

🍽️ Dietary Restriction and Anxiety

Three months of progressive food avoidance is no longer a diagnostic strategy — it has become a behavioural response to uncertainty that is causing harm. Cutting out dairy, wheat, and nuts without any specific trigger confirmed means Ayesha is removing entire food groups from her diet while still having daily urticaria. The persistence of symptoms despite restriction should itself be the signal that diet is not the cause — but anxiety prevents this logical conclusion.

"I want to reassure you about the diet: in a condition like yours that has been present every day for three months, food allergy is actually very rarely the cause. The fact that the symptoms have continued despite all your restrictions strongly suggests it is not food-driven. I would like you to feel safe returning to a normal varied diet."

💼 Occupational Impact

Ayesha is a nurse — chronic pruritus disturbing sleep, visible facial swelling, and the sedation risk of antihistamines are all occupationally relevant. Sedating antihistamines would be unsafe in her role. Poor sleep from nocturnal itch affects clinical judgement and patient safety. This is a patient for whom treatment adequacy directly affects workplace safety and should be escalated appropriately.

"I want to make sure the medication I prescribe is safe for nursing — so I am choosing a non-sedating antihistamine specifically. And I want to get the dose right so your symptoms are controlled well enough that your sleep improves."

😔 Depression and Anxiety from Chronic Itch

Chronic itch (pruritus) is one of the most psychologically aversive symptoms in medicine. Animal models show that chronic itch activates the same neural circuits as chronic pain. PHQ-9 and GAD-7 in any patient with significant chronic urticaria. Sleep deprivation, food restriction, and social anxiety about visible swelling all compound this. The combination of anxiety + restriction + sleep deprivation creates a stress-urticaria feedback loop that worsens CSU.

"How has your mood been through all of this? Chronic itching that disrupts your sleep is genuinely exhausting — it affects mood, energy, and how you feel about yourself. I want to make sure we are looking after that as well."

🧘 Stress and the Itch-Scratch Cycle

Psychological stress is one of the most reliable exacerbants of CSU — cortisol fluctuations and psychological stress directly lower the mast cell degranulation threshold. The anxiety about food, work performance from sleep deprivation, and the uncertainty of the diagnosis are all feeding back into the urticaria. Breaking the stress-itch cycle is as therapeutically important as the correct antihistamine dose.

"Stress is one of the most consistent things that makes urticaria flare. Getting the medication right will help break the cycle — but managing stress levels will also help the skin condition settle."

🌙 Sleep Disruption and Antihistamine Choice

Nocturnal pruritus in urticaria is particularly severe because cortisol levels are at their nadir overnight (lowest anti-inflammatory activity) and the attention bias that occupies the mind with other concerns during the day is absent. First-generation sedating antihistamines (chlorphenamine) are sometimes used specifically for nocturnal itch — but are unsafe for a nurse and have a short duration of action. Non-sedating antihistamines at 4× dose with a bedtime administration time are more appropriate.

"If the itching is particularly bad at night, it is worth taking your antihistamine in the evening rather than the morning — it lasts long enough that a bedtime dose will be active through the night when the itch is worst."

🔮 Prognosis — Spontaneous Remission

Chronic spontaneous urticaria has a reasonably favourable natural history: approximately 50% achieve complete remission within 1 year, and 80–90% within 5 years. The prognosis is worth communicating explicitly — patients living with chronic daily urticaria often imagine this is their permanent state. The therapeutic value of accurate prognostic reassurance should not be underestimated.

"I want to tell you something that I think will help: this type of chronic urticaria tends to improve on its own over time — about half of people are completely clear within a year. It does not mean permanent chronic disease. The medication I am prescribing today is to manage it well while the body adjusts."

🎓 SCA Checkpoint — Step 1TasksRelating to OthersGlobal Skills

Key phrases that score

"I notice from your medication list that you are on ramipril — an ACE inhibitor blood pressure tablet. This class of medication is a well-recognised cause of the type of lip swelling you are describing. I want to stop that medication today and explain why."

"I want to reassure you about the dietary restriction. In a condition that has been present every day for three months, food allergy is very rarely the cause. Your symptoms have continued despite all the restrictions, which actually suggests food is not the trigger."

"Has the swelling ever affected your throat — or changed your voice? That is the specific symptom I would treat as an emergency."

Deductions

Not identifying ramipril as a cause of angioedema — the most important clinical finding in this case
Reinforcing the food allergy hypothesis without challenging it with evidence
Not screening for laryngeal/throat involvement explicitly
Not asking about NSAIDs or other precipitating drugs
Prescribing a sedating antihistamine to a healthcare worker

🔴 Red

Ramipril not identified; food allergy hypothesis reinforced; throat involvement not screened; sedating antihistamine prescribed; diet restriction not addressed; drug history incomplete

🟠 Amber

Ramipril mentioned but not stopped today; throat screen done but response not linked to EpiPen prescription; diet restriction noted but not challenged; antihistamine dose not optimised; ICE partial

🟢 Green

Ramipril identified + stopped today; switch explained; throat/laryngeal screen; diet restriction challenged with evidence; non-sedating antihistamine up to 4× dose; HAE family history screened; UAS7; ICE all three; occupational safety (non-sedating); prognosis shared; closing question

Step 2

Triage Engine — Emergency · Urgent · Routine

▲collapse

Urticaria triage has one absolute emergency: any current or evolving throat, tongue, or laryngeal angioedema. Beyond the airway emergency, triage identifies same-consultation clinical obligations (stopping ACE inhibitors), urgent investigations (suspected HAE), and the routine management pathway for chronic spontaneous urticaria. Never allow a patient with current throat symptoms to leave the room — assess the airway first.

🔴 Emergency

999 / Immediate Adrenaline

Airway risk — act without delay

Current laryngeal angioedema — stridor, voice change, throat tightness, difficulty breathingAdrenaline IM 0.5mg (1:1000) into mid-outer thigh + 999. Lie flat. IV access. Do not send patient to pharmacy or walk them to resus — call 999 to the room.
Rapidly progressive facial/tongue angioedema — enlarging visibly during consultationAdrenaline IM even without stridor — do not wait for airway compromise. 999. Chlorphenamine 10mg IV + hydrocortisone 200mg IV if available.
Anaphylaxis — urticaria + cardiovascular or respiratory compromiseAdrenaline IM. Lie flat. 999. Second adrenaline at 5 min if no improvement. Document trigger.

🟠 Urgent — Same Consultation

Act Today

Same appointment; do not defer

ACE inhibitor identified as angioedema cause — stop todayStop ramipril (or equivalent ACE-I) at this consultation; start calcium channel blocker (amlodipine) for BP; counsel about 10–15% ARB cross-reactivity; document in allergy field; prescribe 2× EpiPen if previous throat involvement
Suspected HAE — non-itchy angioedema without urticaria + family historyUrgent immunology referral within 2 weeks; arrange C4 (screening), C1q, C1-EI level and function; prescribe icatibant 30mg subcutaneous for acute attacks while awaiting confirmation; stop combined OCP immediately
Urticarial vasculitis suspected — lesions >24h, painful, leave bruisingPunch biopsy referral (dermatology); complement screen (C3, C4); ANA, dsDNA; do NOT just increase antihistamines
History of throat/tongue involvement — first EpiPen prescriptionTwo EpiPen 300mcg prescribed; self-injection training; written anaphylaxis action plan; 999 instruction even after EpiPen use

🟢 Routine

GP-Managed CSU

Antihistamine + monitoring

Chronic spontaneous urticaria — no angioedema, no throat involvement, no drug causeNon-sedating antihistamine up to 4× standard dose; UAS7 baseline; chronic urticaria bloods (FBC, TFTs, CRP); review 4–6 weeks; refer dermatology/allergy if refractory
Acute urticaria <6 weeks — viral trigger suspectedCetirizine 10mg BD for 7–14 days; reassure self-limiting in most cases; return if persists beyond 6 weeks
Chronic inducible urticaria (physical triggers) — stableAntihistamine; trigger avoidance education; allergy clinic if cold urticaria (EpiPen needed)

🎓 SCA Checkpoint — Step 2TasksGlobal Skills

Triage reasoning

"There is something I want to address today before we talk about long-term management: the ramipril you are on for your blood pressure. ACE inhibitors — the class of drug that includes ramipril — are a well-recognised cause of lip and facial swelling, and I believe this may be contributing to your symptoms. I want to stop that medication today and switch you to a different blood pressure tablet."

Deductions

Deferring the ACE-I stop to a future appointment — this is a same-consultation decision
Not triaging throat symptoms before taking full history
Not prescribing EpiPen for patient with previous throat/tongue involvement

🔴 Red

ACE-I not stopped; throat symptoms not triaged first; EpiPen not prescribed despite throat history; HAE not considered

🟠 Amber

ACE-I identified but not stopped today; throat screening done but EpiPen not mentioned; HAE not screened; triage reasoning not shared with patient

🟢 Green

ACE-I stopped at this consultation; throat involvement screened first; EpiPen prescribed if throat history; HAE family history asked; BP management plan given (amlodipine); triage reasoning explained

Step 3

Do I Need This Examination?

▲collapse

The examination in urticaria serves several purposes: confirming the diagnosis from lesion morphology, identifying physical trigger patterns (dermographism), assessing angioedema severity, and excluding systemic disease associations (thyroid, autoimmune). The examination findings must be documented carefully because urticaria resolves quickly and the doctor may only observe normal skin — the history remains the primary diagnostic tool.

Examination	Why it matters	What finding changes management	Changes?
Skin lesion morphology and distribution	Classic urticaria: raised, erythematous wheals with surrounding flare; intensely pruritic; any body site; blanches on pressure; resolves within 24 hours leaving no marks. Key distinguishing feature: wheals move and change — a patch present in the morning may have gone by the afternoon. Fixed, persistent lesions that do not move = not urticaria.If wheals are present in the consultation: note the size, distribution, and any central clearing. Photograph with patient consent — the photograph provides documentation that may not be available at specialist appointments.	Classic wheals resolving within hours → urticaria confirmed. Fixed lesions >24h + central clearing → erythema multiforme; different management. Fixed lesions + pain + bruising → vasculitis biopsy. Generalised → CSU. Linear wheals after skin scratch → dermographic urticaria.	YES — distinguishes urticaria from vasculitis/EM
Dermographism test (firm skin stroke)	Symptomatic dermographism (factitious urticaria): a firm stroke of the skin with a blunt instrument (fingernail, tongue depressor) causes a linear wheal and flare within 2–3 minutes. The most common form of chronic inducible urticaria. Present in ~5% of the general population. The dermographism itself may be asymptomatic (simple dermographism — common, not a condition) or symptomatic (itchy, disruptive — requires antihistamine).The dermographism test can be performed in any GP consultation — no equipment required beyond a fingernail pressed firmly. A positive test in a patient with chronic urticaria is a clinically meaningful finding that changes management (avoidance of friction/rubbing triggers).	Symptomatic dermographism → manage as chronic inducible urticaria; antihistamine; educate about friction triggers. Negative dermographism → not factitious urticaria; proceed with full CSU workup.	YES — identifies most common inducible urticaria
Angioedema assessment — tongue, lips, periorbital, oropharynx	Assess severity of current angioedema: lip thickness bilaterally; tongue — is it visibly enlarged? Is the uvula visible? Can the patient open the mouth fully? Any stridor (listen with stethoscope over larynx)? The assessment must happen before the history in any patient attending with active angioedema — severity determines whether this is a 999 call or a routine assessment.Periorbital angioedema (around eyes) is dramatically visible and frightening but rarely causes airway compromise. Tongue/pharyngeal/laryngeal angioedema is the life-threatening form — the visible appearance of the periorbital swelling does not predict the throat involvement.	Stridor or laryngeal compromise → adrenaline + 999 immediately. Tongue enlarged or uvula displaced → high-risk; 999. Lip swelling only, no throat → EpiPen prescription; safety-net; same-day management. No current angioedema → history guides risk stratification.	YES — determines emergency pathway vs routine
Thyroid examination	Autoimmune thyroid disease is the most common autoimmune association in CSU. Goitre (diffuse = Graves'; nodular = multinodular or Hashimoto's) supports the autoimmune aetiology. Thyroid tenderness suggests subacute thyroiditis. Tachycardia, tremor, heat intolerance, weight loss with urticaria → Graves' disease; clinical findings confirm biochemical suspicion.Treating hypothyroidism or Graves' disease in a patient with both conditions does not reliably resolve the urticaria. However, documenting the association is important — TFTs and TPO antibodies are standard in chronic urticaria investigation.	Goitre → TFTs + TPO antibodies; refer to endocrinology if confirmed. Normal thyroid examination → TFTs still warranted as part of chronic urticaria screen (biochemical thyroid disease without palpable goitre is common).	Context — confirms need for thyroid bloods
BP and HR (haemodynamic assessment)	Any haemodynamic compromise (hypotension, tachycardia, pallor, diaphoresis) in the context of urticaria = anaphylaxis until proven otherwise. Must be checked in any acute or active presentation. Also relevant in Ayesha's case: ramipril was prescribed for hypertension — what is her BP now that we are stopping her ACE inhibitor? Need to confirm a BP management plan.	Haemodynamic compromise → anaphylaxis protocol immediately. Hypertension persisting → start amlodipine 5mg OD as ACE-I replacement for BP management. Normal BP → monitor after stopping ramipril; return in 4 weeks for BP recheck.	YES — anaphylaxis screen and BP management
Skin signs of systemic disease (butterfly rash, purpura, lymphadenopathy)	Urticaria as a systemic disease manifestation: butterfly facial rash + arthralgia + urticaria-like lesions >24h = possible SLE with urticarial vasculitis. Purpura (non-blanching) + urticaria = cryoglobulinaemia or vasculitis. Lymphadenopathy + urticaria + weight loss = possible lymphoma (paraneoplastic urticaria). These are rare but important not to miss.	Butterfly rash → ANA, dsDNA, complement; rheumatology. Non-blanching purpura → vasculitis; haematology/rheumatology urgently. Lymphadenopathy + B symptoms → haematology; CT scan. Normal → CSU with no systemic disease features; routine management.	Context — screens for systemic disease

🎓 SCA Checkpoint — Step 3Tasks

Examination with explanation

"I would like to check your skin today, look at the lips and throat to assess the swelling, and check your blood pressure — since I am planning to stop the ramipril, I want to make sure we have a clear blood pressure management plan before you leave."

Deductions

Not assessing the oropharynx in a patient with lip swelling
Not checking BP when stopping an antihypertensive drug
Not performing dermographism test in suspected chronic inducible urticaria

Step 4

Do I Need This Investigation?

▲collapse

Acute urticaria (<6 weeks) does not routinely require investigation — most cases are self-limiting viral or idiopathic and investigations do not change management. Chronic urticaria (≥6 weeks) warrants a standard screen for associated conditions. Specific investigations are added when clinical features suggest HAE, vasculitis, systemic disease, or IgE-mediated allergy to a specific trigger. Extensive allergy testing panels without a specific hypothesis are not indicated in CSU and generate false positives that drive more unnecessary restriction.

Investigation	When indicated	What result changes management
FBC, CRP, ESR	Standard screen for chronic urticaria (≥6 weeks). FBC: eosinophilia may suggest parasitic infection or eosinophilic disorder; anaemia in SLE/vasculitis. Elevated CRP/ESR supports inflammatory or infectious cause. Normal results support idiopathic CSU.	Elevated eosinophils → stool ova and parasites (endemic travel); consider tropical parasites. Elevated CRP/ESR with prolonged lesions → urticarial vasculitis screen. Normal → supports CSU; reassuring for patient.
TFTs + TPO antibodies (thyroid peroxidase)	Autoimmune thyroid disease associated with CSU in ~30%. TPO antibodies elevated in ~25% of CSU patients. Hypothyroidism can exacerbate urticaria. Standard component of chronic urticaria screen per BSACI guidelines.	Hypothyroidism → levothyroxine; may modestly improve urticaria. Hyperthyroidism (Graves') → endocrinology referral; carbimazole. TPO antibodies positive alone → document; autoimmune mechanism confirmed; treatment unchanged but may support early specialist referral.
C4 level (HAE screening test)	Most sensitive screening test for hereditary angioedema. C4 is consumed during bradykinin production — it is low both during and between attacks in 95% of HAE cases. C4 normal between attacks makes HAE very unlikely (high negative predictive value). Indicated: recurrent angioedema without urticaria, family history of angioedema, young patient with recurrent unexplained facial or abdominal swelling.	Low C4 → proceed to C1q and C1-EI level AND function. C4 normal → HAE type 1 and 2 very unlikely; consider HAE type 3 (oestrogen-sensitive, normal complement) if clinical suspicion high. C1q low + low C4 → acquired angioedema (secondary to malignancy or autoimmune) — urgent haematology.
C1q, C1-EI level AND function (if C4 low)	C1-esterase inhibitor (C1-EI) deficiency: Type 1 HAE (85%) — low C1-EI level AND function; Type 2 HAE (15%) — normal C1-EI level but low function. Testing both level AND function is mandatory — testing level alone will miss Type 2 HAE. C1q: low in acquired angioedema (secondary to lymphoma or autoimmune), normal in genetic HAE. This distinction is critical.	Low C1-EI level and function → HAE Type 1; immunology referral; C1-EI concentrate for acute attacks. Normal C1-EI level + low function → HAE Type 2; same management. Low C1q + low C4 + low C1-EI → acquired angioedema; investigate for malignancy (haematology).
ANA, dsDNA, C3, C4, complement (if urticarial vasculitis suspected)	Urticarial vasculitis: lesions >24h + painful/burning + leaves bruising. Hypocomplementaemic urticarial vasculitis syndrome (HUVS) strongly associated with SLE. Low C3 + low C4 + positive ANA = SLE with vasculitis. C4 alone low (without C3) in early CSU/HAE. Both C3 and C4 low → activation of classical complement pathway (SLE, cryoglobulinaemia, HUVS).	Positive ANA + dsDNA + low complement → SLE; rheumatology urgent. Hypocomplementaemia alone → HUVS; dermatology/rheumatology. Normal complement → urticarial vasculitis less likely but still biopsy if lesions >24h.
Specific IgE testing (RAST/ImmunoCAP) — only for suspected IgE-mediated allergen	NOT routine in CSU. Only indicated when: clear history of urticaria within 1–2 hours of specific food, drug, or allergen exposure; and the cause is not already identified. Broad allergen panels (e.g. "food allergy panel of 20 items") in CSU generate false positives, drive unnecessary dietary restriction, and do not improve outcomes. Specific IgE testing should be guided by a specific clinical hypothesis.	Specific IgE positive to suspected allergen → confirms IgE-mediated sensitisation; allergy clinic; avoidance; EpiPen if high-risk. Negative specific IgE to suspected allergen → IgE-mediated allergy unlikely; reassure patient; refocus on CSU management.
Urine dipstick + blood pressure reassessment (after stopping ACE inhibitor)	Ramipril was prescribed for hypertension — stopping it requires a BP management plan. Recheck BP at this consultation and again in 4 weeks after starting amlodipine. Urine dipstick for proteinuria: if ramipril was prescribed partly for renoprotection (e.g. in DM or CKD), stopping it requires renal function monitoring.	BP elevated after stopping ramipril → start amlodipine 5mg OD. Proteinuria present → review indication for ACE-I (renoprotection); involve nephrology if significant proteinuria; consider ARB with full counselling about cross-reactivity risk.
Punch skin biopsy (dermatology-arranged — suspected urticarial vasculitis)	The only investigation that definitively distinguishes urticarial vasculitis from urticaria. Biopsy of a lesion >24h shows: neutrophilic perivascular infiltrate + fibrinoid necrosis + endothelial swelling in vasculitis; eosinophilic perivascular infiltrate without vessel wall damage in urticaria. This distinction is critical because management is entirely different (immunosuppression vs antihistamines).	Urticarial vasculitis confirmed → rheumatology/dermatology; immunosuppression (hydroxychloroquine, dapsone, or systemic steroids); underlying cause investigation (SLE, hepatitis, malignancy). Urticaria on biopsy → standard CSU management with antihistamines.

🎓 SCA Checkpoint — Step 4Tasks

Investigation rationale

"Since the urticaria has been present for three months, I am going to arrange a blood test that checks for conditions that can be associated with this type of urticaria — including thyroid function, inflammatory markers, and a blood count. I am not arranging a food allergy panel because in chronic urticaria that has been present every day for months, food allergy is very unlikely to be the cause and those tests generate more confusion than clarity."

Deductions

Ordering a broad food allergy panel without a specific IgE hypothesis
Not checking TFTs as part of chronic urticaria screen
Not checking C4 when HAE features are present
Not rechecking BP after stopping ramipril

Step 5

Reaching a Diagnosis & DDx — Explained in Plain Language

▲collapse

Urticaria is a clinical diagnosis based on morphology and pattern. The most therapeutically important diagnostic acts are: (1) distinguishing histamine-mediated from bradykinin-mediated angioedema (completely different treatment pathways), and (2) classifying the urticaria as acute, chronic spontaneous, chronic inducible, or urticarial vasculitis — each requiring different management.

🗣️ Explaining Urticaria and Angioedema in Plain Language

"Your skin contains cells called mast cells — think of them as tiny capsules filled with histamine and other chemicals. In normal circumstances, they only release these chemicals in response to a genuine threat, like an insect sting. In urticaria, these cells become too sensitive and fire off their chemicals without a real threat — causing the raised, itchy patches that move around. In your case, we think there are two things happening at once: the first is a type of chronic urticaria where the mast cells are overactive — this is called chronic spontaneous urticaria and in about 70% of cases it is driven by the immune system itself rather than anything external. The second is that your ramipril blood pressure tablet — which has been working very well for your blood pressure — belongs to a class that can cause swelling of the lips and face in some people. Not by the histamine pathway, but by a different chemical called bradykinin. I want to stop the ramipril today and switch you to a different type of blood pressure tablet, which should stop the lip swelling."

💬 Addressing the food allergy hypothesis

"I have been avoiding dairy, wheat, and nuts — surely one of those must be causing it?"
"I completely understand why you have been trying to identify a food trigger — it makes intuitive sense. But in a condition that has been present every single day for three months, and that has continued despite cutting out all those foods, the evidence strongly suggests food is not the cause. True food allergy causes urticaria within 1–2 hours of eating the specific food, and stopping that food stops the symptoms reliably. What you are describing is daily symptoms regardless of what you eat. That pattern is much more consistent with what we call chronic spontaneous urticaria — where the immune system itself is the driver, not an external trigger. I would like you to feel safe going back to a normal varied diet."

A — GP-Diagnosed and Managed

Clinical diagnosis — no biopsy needed

Chronic Spontaneous Urticaria (CSU)

Urticaria ≥6 weeks without consistent physical trigger. 70% autoimmune mechanism. No single cause identified. Antihistamine up to 4× standard dose first-line. Spontaneous remission in 50% within 1 year.

ACE Inhibitor Angioedema

Bradykinin-mediated. No urticaria or itch. Can occur at any time during ACE-I therapy. Stop ACE-I immediately. Antihistamines unreliable. Switch to CCB or ARB (10–15% cross-reactivity with ARB).

Acute Urticaria (Viral/Drug/Idiopathic)

Duration <6 weeks. Often post-viral or drug-induced. Antihistamine for symptomatic relief. Usually self-limiting without specific cause identification.

B — Specialist Input Required

Allergy/dermatology/immunology

CSU Refractory to Antihistamines

UAS7 persistently elevated despite 4× antihistamine dose. Dermatology/allergy referral; omalizumab via specialist (NICE TA339).

Hereditary Angioedema (HAE)

Recurrent non-itchy angioedema without urticaria. Bradykinin-mediated. C4 low. Immunology urgently. Icatibant for attacks. COC absolutely contraindicated.

Cold/Inducible Urticaria with Anaphylaxis Risk

Cold urticaria — risk of anaphylaxis on cold water immersion. Allergy clinic; EpiPen mandatory; cold stimulation testing.

C — Emergency / Biopsy Needed

Urgent — do not manage as simple urticaria

Urticarial Vasculitis

Lesions >24h, painful/burning, leave bruising. Biopsy + complement screen + ANA/dsDNA. Associated with SLE, hepatitis, malignancy. Requires immunosuppression.

Anaphylaxis (Urticaria + Cardiovascular/Respiratory)

Adrenaline IM + 999 immediately. Two EpiPens on discharge. Written action plan. Allergy clinic referral for trigger identification.

📊 Angioedema Mechanism — Critical Classification

Type	Mechanism	Urticaria present?	Antihistamine works?	Adrenaline works?	Key management
ACE-I Angioedema	Bradykinin accumulation (ACE inhibited → no bradykinin breakdown)	No (usually)	Unreliable	Unreliable	Stop ACE-I permanently. Icatibant (bradykinin antagonist) for severe attacks. Switch to CCB or ARB.
HAE (Hereditary)	C1-EI deficiency → uncontrolled complement + bradykinin generation	No — distinguishing feature	Do NOT work	Do NOT reliably work	C1-EI concentrate or icatibant for attacks. Lanadelumab for prophylaxis. Never COC.
Allergic (IgE-mediated)	IgE + allergen → mast cell degranulation → histamine + bradykinin	Yes — usually with urticaria	Yes — effective	Yes — first-line	Allergen avoidance. Two EpiPens. Allergy testing for trigger. Antihistamine for urticaria.
CSU with Angioedema	Autoimmune mast cell activation → histamine release	Yes — urticaria present	Yes — up to 4× dose	Sometimes needed if laryngeal involvement	Non-sedating antihistamine up to 4× dose. Omalizumab if refractory. EpiPen if throat involvement.

🎓 SCA Checkpoint — Step 5TasksRelating to Others

Diagnosis in plain language

"The lip swelling is most likely caused by your ramipril — it works through a completely different chemical pathway from the itch, which is why the loratadine has not helped with the swelling. Stopping the ramipril should stop the angioedema. The itchy hives are a separate condition — chronic spontaneous urticaria — which is usually driven by the immune system itself and is best treated with non-sedating antihistamines at an effective dose."

Deductions

Not distinguishing bradykinin-mediated (ACE-I, HAE) from histamine-mediated angioedema
Not explaining why antihistamines do not reliably work for ACE-I angioedema
Not challenging the food allergy model

Step 6

If Referral Is Needed — What the GP Does Before & During

▲collapse

Most acute and chronic urticaria is managed entirely in primary care. Specialist referral is indicated for: CSU refractory to 2× antihistamine dose for 4 weeks; suspected HAE (urgent immunology); urticarial vasculitis (dermatology); cold urticaria with anaphylaxis risk (allergy clinic); anaphylaxis trigger identification (allergy clinic). The GP must optimise antihistamine therapy before referring — specialist appointments are wasted if the patient arrives on a standard 1× antihistamine dose when up to 4× is evidence-based.

Condition	Urgency	What GP does before referral	What GP must NOT do
CSU refractory to antihistamines — omalizumab pathway	Routine dermatology/allergy	Trial two different non-sedating antihistamines at up to 4× standard dose for ≥4 weeks each. Document UAS7 at each visit. Document antihistamine name, dose, duration, and response precisely — required for NICE TA339 funding approval. Arrange baseline bloods. Consider adding montelukast as third-line before referral.	Do NOT refer on standard 1× antihistamine dose — this will waste a specialist appointment. Up to 4× dose must be tried and documented first. Do NOT withhold referral if UAS7 remains high despite 4× dose — omalizumab access requires timely specialist review.
Suspected HAE — urgent immunology	Urgent — 2 weeks	Arrange C4 (screening) concurrently. If C4 low: C1q + C1-EI level + C1-EI function. Prescribe icatibant 30mg SC as "rescue" prescription for acute attacks while diagnosis is pending. Advise stop combined OCP immediately if HAE suspected. Do NOT wait for confirmation before issuing rescue treatment.	Do NOT manage HAE with antihistamines alone — they do not work. Do NOT send patient home without an emergency treatment plan and icatibant if HAE is suspected. Do NOT continue COC in a patient with suspected HAE.
Urticarial vasculitis — dermatology	Urgent — 2–4 weeks	Arrange complement screen (C3, C4), ANA, dsDNA, FBC, ESR/CRP. Biopsy of a fresh lesion: punch biopsy at the edge of a >24h lesion. Photograph the lesion before biopsy for documentation. Do NOT initiate immunosuppression before biopsy confirmation.	Do NOT manage as CSU with antihistamines. Do NOT start systemic corticosteroids before biopsy — this may suppress histological findings and delay diagnosis of underlying SLE.
Anaphylaxis — allergy clinic	Routine allergy clinic	Two EpiPens prescribed and training completed. Written BSACI anaphylaxis action plan. Trigger identified or suspected. Medical alert bracelet advised. Avoid suspected trigger until seen by specialist. Document full episode including timeline, exposure, and treatment given.	Do NOT wait for allergy clinic appointment before prescribing EpiPens — allergy clinic waiting times can be 6–12 months. Every patient with anaphylaxis must leave the consultation with two EpiPens today.
Cold urticaria — allergy clinic	Routine allergy clinic	Prescribe two EpiPens — cold urticaria carries systemic anaphylaxis risk on cold water immersion. Advise: avoid swimming in cold water, avoid drinking ice-cold beverages, pre-medicate with antihistamine before cold exposure. Non-sedating antihistamine at up to 4× dose.	Do NOT dismiss cold urticaria as "just skin hives" — cold water immersion can cause fatal anaphylaxis in cold urticaria. EpiPen prescription is mandatory before allergy clinic is seen.

🎓 SCA Checkpoint — Step 6Tasks

Referral pathway

"My plan today is to start you on an adequate dose of a non-sedating antihistamine, stop the ramipril, and arrange the blood tests. I want to review you in 4–6 weeks. If the symptoms are still significantly affecting your quality of life after trying a higher dose of antihistamine, I will refer you to the dermatology or allergy service — where there is a very effective injection treatment called omalizumab available for exactly this condition."

Deductions

Referring immediately without optimising antihistamine dose first
Not prescribing EpiPen for patient with previous throat/tongue angioedema
Not issuing icatibant if HAE is suspected before specialist is seen

Step 7

Management — Expectation · Goals · Lifestyle · Drug Selector · Drug Cards · Psychosocial · Follow-Up · Safety-Netting

▲collapse

7A — Address expectations: the allergy testing expectation and the ramipril revelation

🤝

The patient is expecting allergy testing — she will receive something more clinically useful: the actual cause

Validate — the diet effort was rational

Three months of dietary restriction represents significant effort and personal sacrifice. Validating this before challenging it creates the rapport needed for the patient to accept that food is not the cause. "You have been doing everything right given what you thought was happening" — then redirect.

"The dietary changes you have been making make complete sense given your theory about food allergy — you were being methodical and thoughtful about it. What I want to share with you today is that I think the evidence points to a different cause entirely, and one that we can act on today."

Explain — the ramipril finding

The revelation that ramipril may be causing the angioedema is clinically significant and potentially frightening. It must be framed as good news (there is a clear cause; stopping it should help) not alarming news (your medication is harming you).

"I have found something in your medication history that I believe is the most likely cause of the lip swelling. Your ramipril — the blood pressure tablet — belongs to a class of medications that can cause this exact type of facial swelling in some people. The great news is that stopping it should stop the swelling. And I have an equally effective blood pressure tablet to switch you to today."

Negotiate — today's concrete plan

Stop ramipril + start amlodipine; optimise antihistamine (cetirizine 10mg BD → 20mg BD if needed); chronic urticaria bloods; food allergy testing deferred with explanation; 4–6-week review; EpiPen if throat history; return-to-normal-diet advice.

"Today I am going to stop the ramipril, start you on a calcium channel blocker for your blood pressure which works just as well and does not cause this type of swelling, increase your antihistamine to a more effective dose for the skin urticaria, arrange the blood tests, and I want you to go home and eat normally. You have been restricting your diet unnecessarily and it is safe to stop."

Key principle: Chronic spontaneous urticaria has two separate clinical problems requiring two separate treatments in this case: the angioedema from the ACE inhibitor (stop ramipril today) and the urticaria from the autoimmune mast cell mechanism (optimise antihistamine). Both must be addressed in the same consultation. Addressing only one leaves the patient inadequately treated.

7B — Treatment goals

Treatment goals

Stop ramipril today; angioedema should resolve within days to weeksUAS7 reduction by ≥50% at 4–6-week review Non-sedating antihistamine optimised to effective dose (up to 4×)BP controlled on amlodipine 5mg OD alternative Return to normal varied diet; dietary restriction stoppedSleep improved with adequate nocturnal antihistamine cover EpiPen prescribed if throat history; written action planReferral to dermatology/allergy if refractory at 4–6 weeks

Motivational language

"In about 50% of people with chronic spontaneous urticaria, the condition resolves completely within a year without any significant intervention. The medication I'm giving you today is to control it while the body's immune system resets itself."

"You are going to be able to eat normally again. The three months of dietary restriction were based on a reasonable hypothesis that the evidence now tells us is unlikely. I want you to have that freedom back."

7C — Non-medication management: what can patients do?

Unlike many conditions, lifestyle changes have limited impact on chronic spontaneous urticaria. The most important lifestyle interventions are: (1) stopping the ACE inhibitor; (2) avoiding NSAID/aspirin aggravation; (3) returning to a normal diet; (4) managing stress (lowers mast cell threshold); (5) wearing loose-fitting clothing for symptomatic dermographism; (6) taking antihistamine at bedtime for nocturnal itch.

💊

Avoid Aggravating Drugs

Stop ACE-I; avoid NSAIDs in NECU

Mechanism

ACE inhibitors (bradykinin accumulation) and NSAIDs/aspirin (COX-1 inhibition → leukotrienes) are the two most important pharmacological aggravants. Opioids cause direct mast cell degranulation.

Practical

Stop ACE-I permanently. NSAIDs: use paracetamol as alternative. Aspirin: avoid analgesic doses; very low dose (75mg) has lower risk. COX-2 selective NSAIDs (etoricoxib) have lower urticaria aggravation risk if NSAID essential.

Stopping ACE-I resolves angioedema in most cases within weeks

🍽️

Return to Normal Diet

No food avoidance unless IgE-confirmed

Mechanism

CSU is rarely food-driven. Dietary restriction in CSU causes nutritional harm, social restriction, and anxiety without clinical benefit. Pseudoallergens (preservatives, colourings, salicylates) can aggravate CSU in a minority — but this does not require elimination, only reduction if clearly symptomatic.

Practical

Advise return to normal varied diet. If patient insists on testing food triggers: structured elimination and reintroduction under dietitian guidance — not self-directed restriction. Confirm: if stopping a food for 2 weeks does not improve symptoms, that food is not the cause.

Removing unnecessary food restriction improves QoL immediately

🧘

Stress Management

Stress reduces mast cell degranulation threshold

Mechanism

Psychological stress directly lowers the threshold for mast cell degranulation via neuropeptide (substance P, CRH) release. Stress-urticaria flares are well-documented. Breaking the anxiety-urticaria cycle is therapeutically important.

Practical

NHS Talking Therapies/CBT for health anxiety and dietary restriction behaviours. Mindfulness. Sleep hygiene. Aerobic exercise (not if exercise-induced urticaria). Adequate sleep reduces urticaria severity — treat nocturnal itch with bedtime antihistamine dosing.

Stress reduction independently reduces urticaria severity

👕

Clothing and Temperature

Loose-fitting clothing; lukewarm water

Mechanism

Pressure and friction from tight clothing can exacerbate symptomatic dermographism and pressure urticaria. Hot showers increase vasodilation and can worsen histamine release. For cold urticaria: avoid cold water exposure, cold drinks, and cold environments without antihistamine pre-medication.

Practical

Loose, natural-fibre clothing. Lukewarm (not hot) showers. For cold urticaria: pre-medicate with antihistamine before cold exposure. For exercise-induced urticaria: avoid eating wheat within 4–6 hours of exercise (wheat-dependent exercise-induced anaphylaxis).

Simple adjustments reduce symptom frequency

💤

Nocturnal Antihistamine Dosing

Bedtime dose for nocturnal itch

Mechanism

Urticaria is typically worse at night due to the cortisol nadir (minimal anti-inflammatory activity) and the absence of daytime distraction. Taking the non-sedating antihistamine at bedtime (rather than morning) maximises coverage during the most symptomatic period.

Practical

Switch antihistamine timing to bedtime. At 4× dose: split dosing (e.g. cetirizine 10mg morning + 30mg evening) or single large bedtime dose — both acceptable. Avoid sedating antihistamines in healthcare workers even for nocturnal use (residual morning drowsiness).

Bedtime antihistamine significantly improves sleep quality

📱

Symptom Diary and Trigger Tracking

UAS7 diary for specialist review

Mechanism

A structured symptom diary (UAS7) quantifies disease activity for specialist referral, treatment response monitoring, and trigger identification. Provides objective evidence of disease burden for NICE omalizumab funding.

Practical

UAS7: rate number of wheals (0–3) and itch severity (0–3) daily for 7 days. Total score 0–42. Apps: CareClinic, allergy diary apps. Keep diary consistently for 4 weeks before specialist review.

UAS7 documentation accelerates omalizumab access

7D — Prescribing guide: BSACI/EAACI stepwise approach

The BSACI and EAACI urticaria guidelines (2022) specify a clear stepwise approach. The most commonly under-implemented step is Step 2 — up-dosing non-sedating antihistamines to 2–4× standard dose. This is the most powerful pharmacological intervention available in primary care for CSU and is frequently omitted because prescribers assume standard dosing is adequate.

Step 1 — Second-Generation Non-Sedating Antihistamine at Standard Dose

Cetirizine 10mg OD or Loratadine 10mg OD or Fexofenadine 180mg OD

Second-generation (non-sedating) antihistamines are first-line — superior efficacy, once-daily dosing, no sedation
Never use first-generation (chlorphenamine, hydroxyzine) as first-line — sedating, short-acting, impair cognition
Take daily (not PRN) in CSU — continuous antihistamine suppression is more effective than intermittent dosing
If inadequate at standard dose after 2 weeks: do not change drug class — increase the dose

BSACI: cetirizine and loratadine are equally effective. Fexofenadine is preferred when any sedation is unacceptable (nurses, drivers, pilots). Cetirizine has slightly higher CNS penetrance than loratadine — some patients prefer loratadine for this reason.

Step 2 — Up-Dose to 2–4× Standard (BSACI/EAACI Endorsed)

Cetirizine up to 40mg/day or Loratadine up to 40mg/day or Fexofenadine up to 720mg/day

BSACI and EAACI guidelines: up-dosing non-sedating H1-antihistamines to 4× the licensed dose is evidence-based for CSU refractory to standard dosing
This is an off-label use in the UK — inform patients and document in notes
Most effective approach: cetirizine 10mg morning + 20–30mg at night; or single 40mg bedtime dose
Trial for 4 weeks before considering further escalation or specialist referral

4× dosing is the single most under-utilised evidence-based intervention in primary care urticaria management. Most patients arrive at specialist clinics on 1× dose when 4× should have been tried first.

Step 3 — Add-On Therapy (Before Specialist Referral)

Montelukast 10mg OD added to antihistamine; or trial of alternative antihistamine

Montelukast (leukotriene receptor antagonist): evidence modest in CSU; more useful in NSAID-exacerbated urticaria (NECU). Add to antihistamine, not replace.
Trial second antihistamine at 4× dose if first was ineffective — cetirizine and fexofenadine have different pharmacokinetics; individual response varies
Short course of prednisolone (25–40mg OD × 3–5 days) for acute severe flares only — not for maintenance. Prolonged steroids worsen long-term outcomes in CSU.

Step 4 — Omalizumab (Specialist — NICE TA339)

NICE TA339: omalizumab (Xolair) 300mg SC monthly licensed for chronic spontaneous urticaria refractory to antihistamines in adults
Eligibility criteria: UAS7 ≥28 (>16) despite treatment with non-sedating H1-antihistamine at licensed dose; specialist-initiated
Mechanism: anti-IgE monoclonal antibody — reduces free IgE, reduces mast cell reactivity
Response rate: ~66% achieve UAS7 = 0 (complete response); onset of effect within 4 weeks in most responders
Duration: reassess after 6 months; consider stopping in complete responders to assess need

ACE-I Angioedema — Specific Management

Stop ACE-I permanently — not temporarily. Never re-challenge. Document in allergy field.
Alternative antihypertensive: amlodipine 5mg OD (calcium channel blocker) — preferred first choice; no angioedema risk
ARB alternative (candesartan, losartan): 10–15% cross-reactivity risk with angioedema — counsel explicitly; monitor closely; do not use if severe previous ACE-I angioedema
HAE acute attacks: icatibant 30mg SC (bradykinin B2 receptor antagonist) — specific treatment; antihistamines and adrenaline less reliable in bradykinin-mediated angioedema
Anaphylaxis co-management: adrenaline IM remains first-line for any acute severe angioedema even if bradykinin-suspected

7E — Medication selection tool

Select clinical scenario — see drug cards below for full guidance

Acute urticaria (<6 weeks) Chronic spontaneous urticaria (≥6 weeks) ACE inhibitor-induced angioedema Suspected HAE (non-itchy angioedema, no urticaria) Previous throat/tongue involvement Healthcare worker / driver (no sedation)

Drug selection guide

Acute urticaria: Cetirizine 10mg BD for 7–14 days; self-limiting. Chronic spontaneous urticaria: Cetirizine 10mg OD → up to 40mg/day (BSACI/EAACI evidence-based); if refractory at 4× dose → dermatology/allergy referral for omalizumab. ACE-I angioedema: STOP ACE-I permanently TODAY; start amlodipine 5mg OD for BP; document in allergy field. HAE: Urgent immunology; icatibant 30mg SC for acute attacks; stop COC immediately. Throat/tongue history: prescribe 2× EpiPen 300mcg + written anaphylaxis action plan + 999 instruction. Healthcare worker: Fexofenadine 180mg OD (lowest CNS penetrance) or loratadine 10mg OD — avoid cetirizine if any cognitive concerns. NEVER first-generation antihistamines as first-line in CSU.

7F — Drug reference cards

Cetirizine (H1-Antihistamine — Non-Sedating)

Cetirizine 10mg tablets · up to 40mg/day in CSU (off-label above 10mg)

✓ Recommended

First-line — standard dose10mg OD → up to 40mg/day (CSU)

✓ Prefer when

First-line for acute and chronic spontaneous urticaria — evidence-based at standard and up-dosed regimens

Daily dosing (not PRN) in CSU — continuous H1 receptor blockade more effective than intermittent

Safe in pregnancy and breastfeeding (NICE: preferred antihistamine in pregnancy)

Up to 4× dose (40mg/day) endorsed by BSACI and EAACI for CSU refractory to standard dose — document as off-label and obtain verbal consent

✗ Avoid / cautions

Mild sedation in some patients (less than first-generation; more than loratadine) — if any concern about drowsiness in a healthcare worker or driver, switch to fexofenadine

Renal impairment: reduce dose (eGFR <30: max 5mg OD). QTc prolongation at very high doses in susceptible patients — ECG if cardiac concerns.

⚠ Side effects

Mild drowsiness (less than first-generation). Dry mouth, headache. At high doses (30–40mg): increased sedation risk — warn patients; monitor occupational safety.

🔬 Monitor

UAS7 at 2 and 4 weeks — has score reduced by ≥50%? If not, up-dose before switching. At 4× dose: confirm patient aware of off-label use. Annual review once stable.

💬 Counselling

"Take this tablet every day — not just when the itch is bad. The antihistamine works best when it is maintaining a constant level in your body. For maximum effect with the itching at night, take your dose in the evening. I am starting you at a higher-than-standard dose because the evidence shows this is much more effective for your type of urticaria."

Up to 4× the licensed dose of non-sedating antihistamine is evidence-based per BSACI/EAACI for CSU. This is the single most under-utilised primary care intervention in chronic urticaria. Prescribing 1× dose without up-dosing is a missed opportunity. Fexofenadine is preferred in healthcare workers with any drowsiness concern.

Fexofenadine (H1-Antihistamine — Least Sedating)

Fexofenadine 120mg / 180mg tablets (Telfast) · up to 720mg/day in CSU

✓ Recommended

Preferred — zero CNS penetrance180mg OD → up to 720mg/day (CSU)

✓ Prefer when

Healthcare workers, drivers, pilots — any occupation requiring full alertness. Fexofenadine has the lowest CNS penetrance of all second-generation antihistamines — true "non-drowsy" even at higher doses

Patient who reports any drowsiness on cetirizine or loratadine

Up to 720mg/day endorsed by BSACI/EAACI for refractory CSU

✗ Avoid / cautions

Grapefruit juice, apple juice, and orange juice reduce fexofenadine absorption by up to 50% — take with water, not fruit juice

Antacids (containing aluminium or magnesium hydroxide) reduce absorption — take 2 hours apart

⚠ Side effects

Minimal — headache, nausea in a small minority. No significant sedation even at 4× dose. No cardiac effects at therapeutic doses.

🔬 Monitor

UAS7 at 4 weeks. Check for interactions: fruit juice, antacids. Annual review once stable. Adequate dose documentation for specialist referral.

💬 Counselling

"This is the antihistamine I am recommending specifically because of your nursing work — it has essentially zero sedating effect, even at higher doses. Take it with water rather than fruit juice, as juice can reduce how much of the tablet gets absorbed. Take it every day."

Fexofenadine is the preferred antihistamine for healthcare workers and drivers — lowest CNS penetrance of all second-generation antihistamines. Fruit juice interaction: critical to counsel. Up to 720mg/day is BSACI-endorsed for CSU. This drug choice demonstrates awareness of occupational safety.

Montelukast (Leukotriene Antagonist — Add-On)

Montelukast 10mg tablets (Singulair) — add-on to antihistamine in NECU/CSU

✓ Recommended

Add-on — third-line in CSU10mg OD — added to antihistamine

✓ Prefer when

NSAID-exacerbated chronic urticaria (NECU) — montelukast counteracts the leukotriene pathway activated by NSAIDs/aspirin; best evidence in this subgroup

Add-on to antihistamine in CSU partially responding to 4× antihistamine — modest additional benefit in some patients

Step 3 therapy before specialist referral — worth a 4-week trial

✗ Avoid / cautions

MHRA 2019 warning: neuropsychiatric events (sleep disturbance, nightmares, depression, suicidal ideation, aggression) — rare but serious

Advise patients to report any mood change, sleep disturbance, or unusual thoughts. Review at 4 weeks. Discontinue if neuropsychiatric symptoms develop.

⚠ Side effects

Generally well tolerated. Headache, GI upset. Neuropsychiatric events (rare but MHRA black-box warning): insomnia, nightmares, depression, suicidal ideation — counsel and review.

🔬 Monitor

UAS7 at 4 weeks — if no additional benefit: discontinue; do not persist with ineffective add-on. PHQ-9 at 4-week review. MHRA: discuss neuropsychiatric risk at initiation.

💬 Counselling

"This tablet works on a different pathway from the antihistamine and can add some extra control of the itching for some people. Take it in the evening. I need to tell you about a small but important side effect: very rarely, this tablet can cause changes in mood, sleep, or unusual thoughts. If you notice anything like that, stop the tablet and contact us."

Montelukast in CSU: modest evidence; best in NSAID-exacerbated urticaria. MHRA 2019 neuropsychiatric warning must be discussed at initiation. Step 3 — add to antihistamine, do not replace. Trial for 4 weeks; discontinue if no benefit. PHQ-9 at review.

Omalizumab (Anti-IgE Biologic — Specialist Only)

Xolair 300mg SC monthly — specialist-initiated per NICE TA339

✓ Recommended

Specialist — NICE TA339300mg SC monthly; specialist-initiated

✓ Eligible when

CSU refractory to antihistamines — NICE TA339: UAS7 ≥28 despite non-sedating H1-antihistamine at licensed dose; adult patients

Response rate: ~66% achieve complete response (UAS7 = 0); onset within 4 weeks in most responders

Mechanism: anti-IgE monoclonal antibody — reduces free IgE, downregulates FcεRI on mast cells, reduces mast cell reactivity

✗ Avoid / cautions

Not initiated in primary care — specialist dermatology/allergy only

Risk of anaphylaxis to omalizumab injection (~0.2%) — must be given in a supervised setting; observe 30 min post-injection for first three doses; patient trained in EpiPen use before initiation

⚠ Side effects

Injection site reactions (most common). Anaphylaxis (0.2% — give in supervised setting). Arthralgia, headache. No long-term safety concerns identified to date in urticaria use.

🔬 Monitor

UAS7 at 12 weeks — assess response (≥50% reduction = responder). If complete response: consider stopping after 12 months to assess need. Annual UAS7 and drug review. Specialist-led monitoring with GP shared care for anaphylaxis preparedness.

💬 Counselling

"This injection targets the allergic antibody — IgE — that drives the overactive mast cells in your skin. Most people feel a significant improvement within the first few weeks. It is given once a month at the clinic. For the first three injections, we ask you to wait 30 minutes in the clinic afterwards in case of any reaction, which is rare."

Omalizumab requires UAS7 ≥28 + antihistamine failure at licensed dose — document both precisely for NICE TA339 funding. 66% complete response rate. Key SCA point: GP must have tried antihistamines at licensed dose first (NOT necessarily 4× dose for NICE TA339, though 4× is BSACI evidence-based). Specialist-initiated only.

Prednisolone (Short Course — Acute Severe Flare Only)

Prednisolone 25–40mg OD for 3–5 days only

✓ Recommended

Short course only — acute flares25–40mg OD × 3–5 days; not repeated

✓ Appropriate when

Acute severe urticaria flare with significant functional impairment — short course (3–5 days) provides rapid relief while antihistamine is titrated up

Anaphylaxis adjunct (with adrenaline + antihistamine) — not first-line alone

✗ Do NOT use for

Long-term or repeated courses for CSU — BSACI/EAACI: steroids are NOT recommended for long-term management of CSU; they suppress the HPA axis, cause osteoporosis, diabetes, and weight gain without addressing the underlying mechanism; and patients develop steroid dependency with worsening urticaria on withdrawal ("rebound urticaria")

⚠ Side effects (even short course)

Insomnia, mood disturbance, hypertension, blood glucose elevation (significant if diabetic). Rebound urticaria on cessation. Fluid retention. Avoid without clear indication.

🔬 Monitor

BP and glucose if diabetic or hypertensive. No more than 1–2 courses per year maximum. If >3 courses in a year → specialist referral urgently; steroid dependency developing.

💬 Counselling

"I am giving you a 5-day course of steroid tablets to get the current severe flare under control quickly. These are not for regular use — the goal is to use this once to get things under control, then the antihistamine at the right dose should maintain that. If you find yourself needing these frequently, I want to see you — it means the regular treatment needs adjusting."

Prednisolone in CSU: short courses (3–5 days) acceptable for acute severe flares. NEVER for long-term maintenance — steroid dependency, rebound urticaria, and systemic side effects. If patient needs >2 courses per year: specialist referral and antihistamine optimisation, not more steroids.

Icatibant (HAE Acute Attacks) + Adrenaline Auto-Injector

Icatibant (Firazyr) 30mg SC · EpiPen 300mcg IM for anaphylaxis/laryngeal angioedema

✓ Recommended

HAE / Laryngeal angioedemaIcatibant 30mg SC; EpiPen 0.3mg IM

✓ When to prescribe

Icatibant: suspected or confirmed HAE — bradykinin B2 receptor antagonist; specifically targets the bradykinin pathway; effective in ACE-I angioedema and HAE where antihistamines and adrenaline may be unreliable. Prescribed as "rescue" while awaiting immunology confirmation

EpiPen 300mcg: any patient with previous angioedema involving throat, tongue, or larynx — two auto-injectors prescribed; patient trained in self-injection before leaving consultation

Two EpiPens: first may fail; second dose needed while waiting for ambulance

⚠ Critical distinction

In bradykinin-mediated angioedema (HAE, ACE-I): antihistamines and adrenaline have limited efficacy — icatibant or C1-EI concentrate are the specific treatments

Adrenaline IM remains first-line for ANY acute severe angioedema even if bradykinin-suspected — airway security takes priority over mechanism

⚠ EpiPen training — essential before prescribing

Demonstrate using trainer device. Confirm patient knows: when to use (throat symptoms, difficulty breathing, collapse); how to use (outer thigh, through clothing); that 999 must be called even after using EpiPen. Written action plan provided. Annual training review.

🔬 Monitor

Annual EpiPen review — expiry date; technique; still clinically indicated? Two pens always. Medical alert bracelet advised. Wallet action plan card. HAE: icatibant + immunology monitoring of C4 and clinical activity.

💬 Counselling

"This auto-injector is for emergencies — if you develop throat tightness, voice change, or difficulty breathing. Use it into your outer thigh — it goes through clothing. Then call 999 immediately — the injection gives you time while the ambulance comes, it does not replace it. If you use the first one and are not improving after 5 minutes, use the second one."

Two EpiPens: always prescribe two. Patient must call 999 even after using EpiPen. HAE: adrenaline has limited efficacy — icatibant is the specific treatment for bradykinin-mediated angioedema. In acute airway compromise from any cause: adrenaline first while icatibant is drawn up. Annual training review mandatory.

7G — Psychosocial impact: the invisible illness, dietary isolation, and occupational safety

🫂

Chronic urticaria — the itch that wears you down, the swelling that frightens, the diet that imprisons

Chronic urticaria causes disability that is invisible to others. Ayesha looks completely normal when not having an active episode. But the daily pruritus disrupting sleep, the anxiety about eating in restaurants, the fear of the next swelling episode, and the uncertainty about the cause create a chronic low-grade distress that accumulates. Healthcare professionals with conditions affecting their work are also dealing with professional identity threat alongside physical suffering.

🍽️

Dietary Restriction and Social Isolation

Three months of progressive food avoidance means Ayesha cannot eat freely at work canteens, social events, or restaurants. She is reading ingredient labels, refusing shared food, and declining invitations because of food anxiety. This is causing significant social isolation and is driving an obsessive monitoring behaviour that perpetuates anxiety.

The most therapeutic act is permission to eat normally — confirmed by a clinician who has reviewed the evidence. "You are safe to eat normally" is both medically correct and psychologically liberating.

"I want to give you explicit permission to eat normally again. The evidence tells us clearly that food is not driving your symptoms. You have been restricting unnecessarily for three months — I want you to go home today and eat whatever you would like."

💼

Occupational Safety and Competence

Poor sleep from nocturnal itch affects clinical judgement for a nurse — this is a patient safety issue as well as a personal health issue. First-generation sedating antihistamines would be unsafe in this context. The correct antihistamine choice (fexofenadine) is the appropriate response to occupational context.

Visible facial swelling (lip and periorbital angioedema) also carries a professional dignity dimension — a nurse whose face is visibly swollen may feel professionally compromised and self-conscious in front of patients.

"I am choosing fexofenadine specifically because you are a nurse — it has no sedating effect whatsoever, even at the higher dose I am prescribing. Your clinical judgement needs to be unimpaired."

😰

Fear of Angioedema Recurrence

Intermittent unpredictable lip swelling creates anticipatory anxiety — every meal, every medication, every new environment becomes a potential trigger to fear. This hypervigilance exhausts cognitive resources and perpetuates the stress-urticaria cycle.

Providing a clear mechanism (the ramipril was likely causing the angioedema; stopping it should stop it) converts fearful uncertainty into confident prediction. "When we stop the ramipril, the swelling should stop" is one of the most reassuring clinical statements available in this condition.

"I think we have found the cause of the swelling — and I think when we stop the ramipril, you will find it stops. That will take away the uncertainty that has been frightening you every time you eat."

😔

Depression and Sleep

Chronic pruritus activates the same neural circuits as chronic pain — persistent itch causes depression, anxiety, and hyperarousal. Sleep disruption amplifies all of these. PHQ-9 at this appointment and at every review. NHS Talking Therapies/CBT if PHQ-9 ≥10. Adequate antihistamine dosing improves sleep as a direct consequence — documenting sleep improvement as a treatment outcome target makes it visible.

"How has your mood been? Chronic itching at night is genuinely depleting — it is not just uncomfortable, it affects your whole emotional resilience. Getting the treatment right should make a real difference to how you feel."

🔮

Prognosis — Spontaneous Remission

50% of CSU patients achieve complete remission within 1 year. 80–90% within 5 years. This prognostic information is therapeutic — patients living with daily symptoms assume it is their permanent state. Framing CSU as a time-limited condition (in most cases) changes the patient's psychological relationship with the diagnosis.

"About half of people with your type of urticaria find it has completely resolved within a year. It does not mean permanent chronic illness. The medication is helping you manage it while the body's immune system recalibrates."

📋

Healthcare Professional Context

Nurses and doctors often present late because they self-diagnose, self-treat, and tolerate worse symptoms than they would accept in their patients. Ayesha has been managing this for three months without coming to the GP. Normalising help-seeking for healthcare professionals, and acknowledging that self-management has limits, is part of the psychosocial response.

"I know as a nurse you probably tried to manage this yourself first — and you did the right thing coming in. The connection to the ramipril is something that takes a fresh pair of eyes to spot when you are living with the symptoms daily."

7H — Follow-up schedule

2 Weeks — Angioedema Resolution Check

Has the lip/facial swelling stopped since discontinuing ramipril? This is the most important early outcome — ACE-I angioedema typically resolves within days to weeks of stopping the drug. BP on amlodipine — adequate control? Antihistamine dose — tolerating the higher dose? Any side effects (sedation, headache)? Diet restriction: has patient returned to normal diet? UAS7 score compared to baseline.

Angioedema resolution = ACE-I confirmed as causeBP check after ACE-I stop

4–6 Weeks — Urticaria Response Review

UAS7 score at this appointment vs baseline. Has ≥50% reduction been achieved? If yes: continue current dose; step down to consider after 3 months' symptom control. If no: up-dose to 4× (40mg cetirizine or 720mg fexofenadine); add montelukast 10mg OD as trial. Chronic urticaria blood results reviewed (TFTs, FBC, CRP). PHQ-9. Sleep improvement noted?

UAS7 ≥50% improvement targetUp-dose if partial response

3 Months — Stability Assessment and Referral Decision

If UAS7 = 0 and no angioedema: trial step-down of antihistamine over 4 weeks; 50% of CSU enters remission within 1 year. If UAS7 still ≥16 despite 4× antihistamine: refer to dermatology/allergy for omalizumab assessment (NICE TA339). Blood results fully reviewed. Montelukast response (if added) assessed. PHQ-9. Return to normal diet confirmed.

Refractory (UAS7 ≥16 at 4× dose): refer for omalizumabComplete response: trial step-down

Annual Review

Has urticaria resolved spontaneously? (50% at 1 year, 80–90% at 5 years.) Annual BP check (ongoing — ramipril permanently stopped). EpiPen review: expiry date; still needed? Technique refreshed? UAS7 — current activity. PHQ-9. Any new drugs started? Any new NSAIDs? Any autoimmune symptoms developing (joint pain, fatigue, photosensitivity)? If on omalizumab: specialist annual review.

Annual BP + EpiPen reviewConsider stopping antihistamine trial if 6+ months' remission

Any-Time — Emergency Protocol

Throat tightness, voice change, stridor, difficulty breathing or swallowing = use EpiPen, call 999, do not drive to GP or A&E alone. After any angioedema episode: review at next available appointment; consider whether EpiPen regimen needs updating; if HAE not yet confirmed — expedite immunology. Anaphylaxis with urticaria: EpiPen + 999 + allergy clinic referral triggered.

Laryngeal symptoms: EpiPen + 999 — never drive to A&E

7I — Monitoring: UAS7, drug safety, and BP post-ACE-I

Memory rule — urticaria monitoring framework

At every urticaria review: UAS7 score (0–42; ≥28 = biologic threshold; ≥50% reduction = adequate response); angioedema episodes (frequency, location, trigger — any new throat involvement?); antihistamine dose (is it at the evidence-based up-dose?); drug history review (any new NSAIDs, ACE-I, opioids?); BP post-ACE-I stop (confirm amlodipine controlling BP); EpiPen (valid? technique current? still indicated?); PHQ-9 (chronic itch → depression).

Parameter / Drug	Test	Timing	Action threshold
UAS7 (disease activity)	Patient self-reported diary	Every appointment	≥28 on optimised antihistamine → specialist referral for omalizumab. ≥50% reduction at 4–6 weeks → current regimen effective. UAS7 = 0 for 3+ months → consider antihistamine step-down trial.
BP monitoring (after stopping ACE-I)	BP at every appointment for 6 months post-change	2 weeks; 4–6 weeks; 3 months; annually	BP >140/90 on amlodipine 5mg → increase to 10mg OD or add second agent. Note: no ACE inhibitor or ARB without specific cardiology review of angioedema risk vs renoprotection benefit.
Antihistamine safety (high-dose)	Clinical review; drowsiness; occupational safety	4–6 weeks post-up-dose	Sedation reported in a healthcare worker → switch to fexofenadine (zero CNS penetrance). QTc concern → ECG at high cetirizine dose in cardiac patients.
EpiPen review	Check expiry; technique; indication still present	Annually	Expired → replace immediately; never leave patient without valid EpiPen. Technique incorrect → retrain. No angioedema for 2+ years → specialist review of whether still needed.
Chronic urticaria bloods (FBC, TFTs, CRP)	Baseline blood test at 6 weeks	At 4–6 weeks; then if clinical change	Abnormal TFTs → treat thyroid condition; reassess urticaria. Raised ESR/CRP persistent → urticarial vasculitis; complement screen; biopsy. Eosinophilia → parasitic screen.

Clinical group	First-line antihistamine	Key note
Acute urticaria (<6 weeks)	Cetirizine 10mg BD × 7–14 days	Usually self-limiting; no investigation needed
CSU — standard dose trial	Fexofenadine 180mg OD or Cetirizine 10mg OD daily	Daily (not PRN); 4-week trial at standard dose
CSU — refractory to standard dose	Up-dose: Cetirizine to 40mg/day or Fexofenadine to 720mg/day	BSACI/EAACI: 4× dose evidence-based; document off-label
Healthcare worker / driver	Fexofenadine (lowest CNS penetrance)	Avoid cetirizine if any sedation concern
Pregnancy	Cetirizine 10mg OD (preferred in NICE guidance)	Loratadine acceptable alternative
HAE acute attack	Icatibant 30mg SC (bradykinin B2 antagonist)	Antihistamines and adrenaline unreliable in HAE; icatibant is specific

7J — Safety-netting: exact phrases + medico-legal rationale

⚠ Three scenario-specific safety-net phrases

Why safety-netting matters beyond clinical care

ACE-I angioedema: document "ramipril (and ACE inhibitor class) permanently stopped — angioedema; documented in allergy record; patient advised never to restart" at every consultation

EpiPen training: document "EpiPen self-injection technique demonstrated; patient able to demonstrate back; when-how-why-call 999 documented; written action plan provided" at every EpiPen prescription

Laryngeal angioedema safety-net: document "patient advised: throat tightness/voice change/breathing difficulty = EpiPen + 999 immediately; do not call GP first; written card given" — this is the most medico-legally critical safety-net in urticaria

Antihistamine up-dosing: document "off-label use of cetirizine at 4× dose discussed; patient aware; BSACI/EAACI evidence base explained; verbal consent obtained" at each up-dose prescription

BP management post-ACE-I: document "amlodipine started; BP monitoring plan in place; ramipril/ACE-I class permanently contraindicated in this patient" at every cardiology-relevant appointment

Diet restriction advice: document "patient advised food restriction is not clinically indicated for CSU; advised to return to normal diet; food allergy panel testing not indicated; explained rationale"

2 WeeksAngioedema resolved post-ACE-I stop? BP on amlodipine? Antihistamine tolerance? Return to normal diet?

4–6 WeeksUAS7 ≥50% reduction? Blood results reviewed; up-dose if partial response; referral if refractory

AnnualBP; EpiPen review; UAS7 current; step-down trial if remission; PHQ-9; any new drug aggravants

🎓 SCA Checkpoint — Step 7 (Final)TasksRelating to OthersGlobal Skills

Closing the consultation

"I am stopping your ramipril today — it is permanently removed from your prescription, and I am adding it to your allergy record. I am starting you on amlodipine for your blood pressure, which works just as well and will not cause the swelling."

"For the urticaria, I am prescribing fexofenadine — chosen specifically because you are a nurse and it has no sedating effect. Take it every day, at a dose that is higher than the standard packet dose but which is supported by evidence for this condition."

"You are safe to eat normally again. There is no food restriction needed. The three months of dietary avoidance were not helping because food was not the cause."

"If the swelling ever affects your throat — any tightness, any voice change, any difficulty breathing — that is when you use the EpiPen and call 999. Not us. Not A&E by car. 999 and EpiPen. Here is a card with that written on it."

"I will see you in 2 weeks to check the swelling has settled since stopping the ramipril, and at 6 weeks to review the urticaria response. Is there anything else you want to ask?"

Deductions — closing

Not stopping ramipril today — the most critical clinical action in this consultation
Not explaining why antihistamines do not reliably work for the angioedema (bradykinin not histamine)
Not giving the dietary restriction reassurance and permission to eat normally
Not providing the laryngeal angioedema safety-net verbally and in writing
Prescribing a sedating antihistamine to a nurse without addressing occupational safety
Not providing a BP management plan after stopping the antihypertensive

Tasks — full criteria

Ramipril permanently stopped; documented in allergy field; "-pril class" named to patient
ACE-I vs histamine mechanism distinction explained
Fexofenadine or cetirizine at up to 4× dose; not sedating antihistamine
Amlodipine started for BP; BP management plan confirmed
EpiPen prescribed (if throat history) with training; written action plan given

Relating to Others — full criteria

Dietary effort validated before being challenged
Food allergy hypothesis gently corrected with evidence
Ramipril revelation framed as good news (cause found; can be fixed) not bad news (your medication was harming you)
ICE all three; occupational safety addressed; prognosis shared (50% at 1 year)
Closing question asked; patient leaves with clear, achievable plan

🔴 Red

Ramipril not stopped; food allergy testing ordered; sedating antihistamine prescribed; laryngeal safety-net absent; no BP plan; dietary restriction not challenged; mechanism distinction not made

🟠 Amber

Ramipril stopped but no explanation; standard antihistamine dose without up-dose counselling; food restriction noted but not challenged with evidence; EpiPen not prescribed despite throat history; BP plan absent

🟢 Green

Ramipril stopped + allergy documented + "-pril class" named + amlodipine started; fexofenadine at up to 4× dose; diet restriction corrected with evidence; ACE-I vs histamine mechanism explained; laryngeal safety-net verbal + written; BP management plan; ICE all three; prognosis given; closing question

"I have had these terrible itchy hives for about three months now — they are all over my trunk and arms, come and go during the day, and I have been getting intermittent lip swelling as well. I have been cutting out lots of foods trying to figure out what is causing it but nothing has helped. I am on loratadine which helps a bit with the itch but does not touch the swelling."

Who you are

Ayesha Patel, 34-year-old Band 6 Registered Nurse working in an orthopaedic ward. Methodical, professional, and somewhat self-managing — she has tried to investigate her own symptoms before coming to the GP. Married, no children. Non-smoker. On ramipril 5mg OD (started 8 months ago by cardiologist for mild hypertension). Takes ibuprofen occasionally for headaches (she does not know this could aggravate urticaria). No known drug allergies documented. Has been eliminating: dairy, wheat, nuts, colourings, preservatives — progressively over 3 months. Her UAS7 score if calculated would be approximately 22–26 at presentation.

Hidden agendas (two layers)

Layer 1 — The food allergy hypothesis: Ayesha is convinced food is the cause. She has been reading allergy websites. She is about to start a full elimination diet. She genuinely believes she needs a food allergy blood test panel — a "RAST test for the major allergens." She expects the doctor to order this. If the doctor agrees and orders it, she will leave satisfied — but treated incorrectly. If the doctor explains why food allergy testing is not indicated for her pattern (with evidence), she will initially resist ("but surely it is worth checking?") and then accept once the mechanism is explained. Her acceptance of the no-allergy-testing decision requires a specific explanation, not just dismissal.

Layer 2 — The ramipril connection (not yet made): Ayesha does not know that ACE inhibitors cause angioedema. She takes her ramipril every morning without connecting it to her symptoms. If the doctor asks "have you noticed any connection between when you started the ramipril and the lip swelling?" she will pause and say "...I started it about 8 months ago... and the lip swelling started... maybe 3–4 months ago? I honestly hadn't thought about that." The connection, once made explicit by the doctor, will produce visible surprise — "I had no idea that was a side effect." This is a pivotal moment in the consultation.

Clinical details if asked

Urticaria: raised itchy red patches, 1–5cm, all over trunk and arms; come and go within hours; present most days; worse at night when trying to sleep; sometimes there are none for a day then they come back
Angioedema: lips — approximately once a week; periorbital once; never affected throat or voice; no difficulty breathing or swallowing
Loratadine 10mg: "helps maybe 50% with the itch, does essentially nothing for the lip swelling"
No consistent food trigger identified despite restriction — "I cut out dairy, no improvement. I cut out wheat, no improvement. I cut out nuts, no improvement."
Ibuprofen for headaches: "twice a week sometimes" — she does not connect this to the urticaria
No family history of angioedema or swelling; no one with HAE features
No thyroid disease, no autoimmune history, no SLE symptoms
PHQ-9 at this visit would be approximately 8 — sleep disrupted, tired, frustrated, some low mood but functioning

Reactions to key moments

When ramipril is identified as angioedema cause: Visible surprise and relief — "I had absolutely no idea. I thought it was the food. Is this really a known side effect?" Then: "So stopping it should stop the swelling?" If told yes — visibly relieved.
When food allergy testing is declined with explanation: Initial resistance — "But isn't it worth checking just to be sure?" Then, when mechanism explained (daily 3-month pattern not consistent with IgE food allergy): "OK... that actually makes sense. I kept thinking if I just found the food I could fix it."
When told she can eat normally: Emotional relief — "Really? I've been dreading eating out. I've been turning down dinner invitations." This is one of the highest-value moments in the consultation from the patient perspective.
When shown the up-dosed antihistamine regimen: "Will the higher dose make me drowsy? I need to be fully alert at work." — This is the cue for the candidate to switch to fexofenadine and explain why.
Challenge line: "I have been reading about omalizumab — the anti-IgE injection — would that work for me?" → Candidate should explain: omalizumab is appropriate for CSU refractory to antihistamines at adequate doses; she has not yet tried adequate-dose antihistamines; correct sequence is antihistamine optimisation first then specialist for omalizumab if needed.

"I have been reading about allergy testing online and I am convinced that if I could just identify the food I am reacting to, I could fix this. Can I have a RAST test for the main food allergens? Also — I read about an injection called omalizumab that treats urticaria. Is that something I should have?"

Resolution: Ayesha will be fully satisfied if the candidate: (1) identifies ramipril as the angioedema cause and stops it today; (2) explains the mechanism (bradykinin not histamine) in terms she can understand; (3) challenges the food allergy hypothesis with evidence and gives explicit dietary liberation; (4) prescribes a non-sedating antihistamine appropriate for a nurse (fexofenadine) at up to 4× dose; (5) provides the laryngeal safety-net with specific instructions; (6) explains the omalizumab pathway (available if needed but antihistamine optimisation first). She will disengage if food allergy testing is ordered without challenge, if a sedating antihistamine is prescribed, if ramipril is not stopped, or if the swelling safety-net is absent.

🏥

Clinic Quick Reference

Urticaria & Angioedema — Clinical Decision Framework

NICE CKS 2023 · BSACI 2022 · EAACI/WAO Guidelines · ACE-I + HAE + CSU

▼expand

🚦 1 — Triage Algorithm

Patient with urticaria and/or angioedema → screen for laryngeal involvement FIRST

↓

🔴 Emergency

Stridor, voice change, throat tightness, difficulty breathing: Adrenaline IM + 999 immediately — laryngeal angioedema
Urticaria + haemodynamic compromise: Anaphylaxis — adrenaline IM + lie flat + 999
Rapidly progressive facial/tongue swelling: Adrenaline IM before stridor — do not wait

Adrenaline first · 999 · Never wait for stridor to develop

🟠 Same-Consultation Action

ACE inhibitor identified: stop permanently today; switch to amlodipine; document in allergy record; prescribe 2× EpiPen if throat history
Suspected HAE (non-itchy, no urticaria, family history): C4 + immunology urgent; icatibant; stop COC
Urticarial vasculitis (>24h, painful, bruises): complement + ANA; biopsy referral

ACE-I: stop today · Never defer to next appointment

🟢 Routine Management

CSU ≥6 weeks: non-sedating antihistamine up to 4× dose; chronic urticaria bloods; 4–6-week review; refer if UAS7 ≥16 at 4× dose
Acute urticaria <6 weeks: cetirizine 10mg BD × 7–14 days; usually self-limiting

4× antihistamine dose first · Omalizumab via specialist

📊 2 — Angioedema Mechanism Matrix & Key Numbers

Angioedema — Critical Mechanism Distinction

ACE-I angioedema: Bradykinin-mediated · No itch · No urticaria · Antihistamines unreliable · Stop ACE-I permanently · Amlodipine or ARB (10–15% cross-reactivity)

HAE: C1-EI deficiency · Bradykinin-mediated · No urticaria · Antihistamines do NOT work · Icatibant/C1-EI concentrate · COC absolute CI

Allergic: IgE-mediated · Histamine · With urticaria + itch · Antihistamines work · Adrenaline works · EpiPen + allergen avoidance

CSU angioedema: Autoimmune mast cell · Histamine · With urticaria + itch · Antihistamines work · EpiPen if throat history

HAE Complement Screen

C4 (screen) — low in HAE Types 1 and 2, both during and between attacks

C1q — low in acquired angioedema (malignancy); normal in genetic HAE

C1-EI level — low in Type 1 (85%); normal in Type 2

C1-EI function — low in BOTH Type 1 AND Type 2 — must test BOTH level and function

Testing level alone misses Type 2 HAE (15% of cases)

Stop ACE-I

Same consultation — never defer. All "-pril" drugs permanently contraindicated.

4× dose

Up to 4× non-sedating antihistamine — BSACI/EAACI evidence-based for CSU

2× EpiPen

Any throat/tongue history — two auto-injectors + training + 999 instruction

UAS7 ≥28

NICE TA339 threshold → omalizumab eligibility (specialist-initiated)

6 weeks

Acute vs chronic urticaria threshold

<24h

Wheal duration — >24h + painful + bruising = urticarial vasculitis (biopsy)

50% at 1yr

CSU spontaneous remission — share this with patients

Fexofenadine

Zero CNS penetrance — preferred for nurses, drivers, pilots

⚠ 3 — Safety-Netting & Monitoring

Follow-up timeline

2 weeks: Angioedema resolved post-ACE-I? BP on amlodipine? Antihistamine tolerated?

4–6 weeks: UAS7 ≥50% reduction? Blood results; up-dose if partial; referral if refractory

1yr

Annual: BP; EpiPen review; UAS7; step-down trial if remission; any new drugs

📌 Broad food allergy panel NOT indicated in CSU — explain why; do not order

🚨 Emergency flags: Stridor / voice change / throat tightness → adrenaline + 999 immediately; rapidly progressive facial/tongue angioedema → adrenaline + 999; urticaria + haemodynamic compromise → anaphylaxis protocol; angioedema without urticaria + family history → HAE screen + icatibant urgently

🛡️ Safety: HAE — COC absolute contraindication (oestrogen triggers attacks); ACE-I — permanent stop, never restart, document "-pril class"; high-dose antihistamine — document off-label use; fexofenadine for healthcare workers/drivers; no sedating antihistamines first-line; omalizumab — anaphylaxis risk with injection; EpiPen training mandatory before prescribing

🎓

SCA Exam Quick Reference

Urticaria & Angioedema SCA — ACE-I + Antihistamine + Safety-Net

Tasks · Relating to Others · Global Skills

▼expand

🕐 12-Minute Consultation Flow

0–1 min

Throat Screen + Open Question

"Before we go through everything — has the swelling ever affected your throat, changed your voice, or made it difficult to breathe? That is the symptom I would treat as an emergency."

Laryngeal screen first — before SOCRATES. Then open: "Tell me about the hives and swelling in your own words."

TasksGlobal Skills

✗ Skipping throat screen · ✗ Starting with SOCRATES before laryngeal emergency excluded

1–4 min

Drug History + Food Allergy Challenge + ICE

"I can see you are on ramipril — I want to ask specifically about that. Have you noticed any connection between when you started it and when the lip swelling began?"

"Tell me about the dietary restriction you have been doing. Have you actually found anything that consistently triggers symptoms within 1–2 hours of eating it?"

ACE-I identified from drug list early. Food allergy hypothesis elicited before challenged. ICE: food model; anxiety about eating; allergy testing expectation.

TasksRelating to Others

4–7 min

Examination + Diagnosis in Plain Language

"I am going to check your blood pressure and look at your lips and throat. I also want to check for dermographism."

"I believe I have found the most likely cause of the lip swelling — your ramipril. It works through a different chemical called bradykinin that antihistamines do not block — which is why the loratadine helped the itch but not the swelling. I want to stop it today."

TasksGlobal Skills

✗ Not checking BP when stopping antihypertensive · ✗ Not explaining the mechanism distinction

7–10 min

Management Plan

"Today: stop ramipril, start amlodipine for blood pressure, increase your antihistamine — I am using fexofenadine specifically because you are a nurse and it has no sedating effect at any dose. I am also arranging the blood tests."

"You can eat normally again. Food was not causing this. I want you to go home tonight and eat whatever you would like."

TasksRelating to Others

✗ Sedating antihistamine to a nurse · ✗ Broad food allergy panel ordered · ✗ Ramipril not stopped today

10–12 min

Safety-Net + Prognosis + Close

"One emergency sign: throat tightness or voice change means EpiPen then 999. Here it is written down. Ramipril must never be restarted — I am adding it to your allergy record as the ACE inhibitor class."

"About half of people with your type of urticaria find it has completely resolved within a year. Is there anything else before we finish?"

TasksGlobal Skills

✗ No laryngeal safety-net written · ✗ No prognosis given · ✗ No closing question

🔴🟠🟢 RAG — All 3 Domains

Tasks

🟢

ACE-I identified + stopped + allergy documented + amlodipine; bradykinin vs histamine mechanism; fexofenadine up to 4× dose; no food allergy panel; food restriction corrected; UAS7; laryngeal safety-net written; EpiPen if throat history; BP management plan; referral threshold communicated

🟠

ACE-I stopped but not explained as permanent or class; standard antihistamine dose without up-dose; food restriction noted not challenged; EpiPen absent; no BP plan; mechanism not distinguished; prognosis not given

🔴

Ramipril not stopped; food allergy testing ordered; sedating antihistamine; laryngeal safety-net absent; no BP plan; dietary restriction reinforced; ICE not explored

Relating to Others

🟢

Dietary effort validated before challenged; ramipril revelation framed as good news; dietary liberation stated explicitly; occupational safety acknowledged; ICE all three; mechanism explained accessibly; prognosis shared; chunk-and-check

🟠

Food restriction noted but not challenged directly; ramipril news delivered without framing; ICE partial; mechanism not explained in patient terms; prognosis absent

🔴

Food allergy hypothesis reinforced; ramipril news alarming not reassuring; no ICE; dietary restriction not addressed; no closing question; patient leaves anxious not empowered

💬 Key Phrases

💭 Challenge food allergy model

"In a condition that has been present every day for three months and continued despite cutting out multiple food groups, food allergy is very unlikely to be the cause. True food allergy causes symptoms within 1–2 hours of that specific food, and stops when you stop eating it."

😟 Ramipril revelation — good news

"I believe I have found the most likely cause of the swelling — your ramipril. This is actually good news: there is a clear cause, we can act on it today, and stopping it should stop the swelling."

🎯 Decline allergy panel with reason

"A broad food allergy panel is not what I would recommend here — not because it is not available, but because the pattern of daily symptoms for 3 months is not consistent with IgE food allergy, and the test results would create more confusion than clarity."

🍽️ Dietary liberation

"You can eat normally again. I want you to go home tonight and eat whatever you would like. The dietary restriction was based on a reasonable hypothesis, but the evidence now tells us food was not the cause."

🔬 Bradykinin mechanism

"Ramipril works through a chemical called bradykinin — a completely different pathway from histamine. This is why the loratadine helps the itch but does nothing for the swelling — antihistamines block histamine but not bradykinin."

📋 Laryngeal safety-net

"Throat tightness, voice change, or difficulty breathing means EpiPen into the outer thigh then call 999. Do not call us first. Do not drive to A&E. Here it is written on this card."

🚫 8 Danger Zones

✗

Ramipril not stopped today→ This is a same-consultation decision. ACE-I-induced angioedema requires permanent cessation of the drug class, documented in the allergy record, at this appointment. Deferring is a medico-legal risk.

✗

Broad food allergy panel ordered→ Not indicated in CSU. Generates false positives, drives unnecessary restriction, wastes resources. Explain WHY it is not indicated — not just decline. The explanation is what scores in Tasks and Relating to Others.

✗

Sedating antihistamine to a healthcare worker→ Chlorphenamine or hydroxyzine are dangerous for nursing staff. Fexofenadine is the correct choice. The drug choice demonstrates awareness of occupational safety — a specific SCA competency.

✗

Laryngeal safety-net absent→ Every patient with angioedema involving lips or face must have the throat emergency safety-net verbally AND in writing. EpiPen + 999 — not call GP. This is a medico-legal documentation requirement.

✗

Standard antihistamine dose without up-dosing→ BSACI/EAACI: up to 4× non-sedating antihistamine is evidence-based for CSU. The patient on 1× dose who "hasn't fully responded" is undertreated. Up-dosing before changing drug class or adding agents is the correct step.

✗

No BP management plan after stopping ACE-I→ Ramipril was prescribed for hypertension. Stopping it without starting an alternative is unsafe. Amlodipine 5mg OD must be started at the same appointment. BP recheck in 2 weeks.

✗

ACE-I vs histamine mechanism not distinguished→ This distinction is the core clinical teaching point. HAE and ACE-I angioedema are bradykinin-mediated — antihistamines and adrenaline have limited/unreliable efficacy. Icatibant is the specific treatment. This distinction determines life-saving treatment choice.

✗

COC continued in patient with HAE features→ Combined OCP is absolutely contraindicated in HAE — oestrogen triggers bradykinin-mediated attacks. If HAE is suspected, stop COC immediately before diagnosis is confirmed. Progestogen-only options are safe.

💊 Drug Quick-Pick by Scenario

CSU — healthcare worker

→Fexofenadine 180mg OD → 720mg

Zero CNS penetrance; take with water not juice

CSU — standard patient

→Cetirizine 10mg → 40mg/day

BSACI: 4× dose evidence-based; daily not PRN

ACE-I angioedema

→STOP ACE-I + Amlodipine 5mg OD

Permanent; document "-pril class"; ARB 10–15% cross-risk

HAE acute attack

→Icatibant 30mg SC

Bradykinin antagonist; antihistamines do NOT work in HAE

Acute urticaria flare

→Short prednisolone 25–40mg × 3–5d

Acute flares only; NOT long-term maintenance

CSU refractory (specialist)

→Omalizumab 300mg SC monthly

NICE TA339; specialist-initiated; UAS7 ≥28

⛔ ACE-I: permanent stop — never restart — document "-pril class" · Bradykinin angioedema (ACE-I/HAE): antihistamines unreliable — icatibant specific · HAE: COC absolute contraindication · Never first-generation sedating antihistamine first-line · Broad food allergy panel not indicated in CSU · Omalizumab: specialist only; antihistamine 4× dose first · Laryngeal angioedema safety-net verbal + written at every consultation

Urticaria & Angioedema · GP Clinical Reasoning Framework v2 · NICE CKS Urticaria (2023) · BSACI Urticaria Guidelines 2022 · EAACI/GA²LEN/EDF/WAO Urticaria Guidelines 2022 · NICE TA339 (Omalizumab) · BNF Chapter 3.4

v2: ACE-I angioedema as primary diagnostic target · Bradykinin vs histamine mechanism matrix · Fexofenadine for healthcare workers (zero CNS penetrance) · BSACI/EAACI 4× antihistamine up-dosing evidence base · HAE complement screen (C4 + C1q + C1-EI level AND function — testing level alone misses Type 2) · COC absolute contraindication in HAE · Food allergy hypothesis challenged with evidence · UAS7 disease activity scoring · Omalizumab NICE TA339 pathway · Laryngeal angioedema safety-net mandatory verbal + written

Teaching clinicians why each step matters — not just what to do · Always consult current BSACI guidelines and BNF · Laryngeal angioedema is a clinical emergency — do not hesitate with adrenaline · Clinical judgement takes precedence over any framework

Urticaria & Angioedema

Red Flags — act before continuing history

Safeguarding Considerations

🚗 Occupational Safety — Driving and Antihistamines

💊 EpiPen Prescribing and Self-Injection Training

🤰 Contraception in Angioedema

🍽️ Nutritional Risk from Dietary Restriction

🍽️ Dietary Restriction and Anxiety

💼 Occupational Impact

😔 Depression and Anxiety from Chronic Itch

🧘 Stress and the Itch-Scratch Cycle

🌙 Sleep Disruption and Antihistamine Choice

🔮 Prognosis — Spontaneous Remission

999 / Immediate Adrenaline

Act Today

GP-Managed CSU

CSU Refractory to Antihistamines

Hereditary Angioedema (HAE)

Cold/Inducible Urticaria with Anaphylaxis Risk

Urticarial Vasculitis

Anaphylaxis (Urticaria + Cardiovascular/Respiratory)

Validate — the diet effort was rational

Explain — the ramipril finding

Negotiate — today's concrete plan

Select clinical scenario — see drug cards below for full guidance

Dietary Restriction and Social Isolation

Occupational Safety and Competence

Fear of Angioedema Recurrence

Depression and Sleep

Prognosis — Spontaneous Remission

Healthcare Professional Context

2 Weeks — Angioedema Resolution Check

4–6 Weeks — Urticaria Response Review

3 Months — Stability Assessment and Referral Decision

Annual Review

Any-Time — Emergency Protocol

Memory rule — urticaria monitoring framework

⚠ Three scenario-specific safety-net phrases

Why safety-netting matters beyond clinical care

🎭 Patient actor brief — click to practise

Who you are

Hidden agendas (two layers)

Clinical details if asked

Reactions to key moments